Western University

Scholarship@Western
Canadian Journal of Surgery

Digitized Special Collections

3-1-1976

Volume 19, issue 2
Canadian Medical Association

Follow this and additional works at: https://ir.lib.uwo.ca/cjs
Part of the Surgery Commons

Recommended Citation
Canadian Medical Association, "Volume 19, issue 2" (1976). Canadian Journal of Surgery. 102.
https://ir.lib.uwo.ca/cjs/102

This Book is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western.
It has been accepted for inclusion in Canadian Journal of Surgery by an authorized administrator of
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca.

March 1976

THE CANADIAN JOURNAL OF SURGERY

Q U IL L O N S C A L P E L

89

This section

provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.

THE CANADIAN CARDIOVASCULAR
This is the third time that the Canadian
Journal of Surgery has published a large
proportion of papers presented at the
annual meetings of the Canadian Cardio
vascular Society. When I approached the
potential contributors on the second occa
sion, in 1973, several were reluctant to
publish their material in a journal with
a circulation of less than 1600; but by 1975
the circulation had exceeded 7000 and the
advantages of rapid publication (5 months
separate the date of the oral presentations
and the date of this issue) and the avail
ability of a journal that reaches all Cana
dian surgeons led to an excellent response.
Six of the eight papers in this issue of
the Journal relate to surgical aspects of
coronary artery atherosclerosis. This disease
has been recognized as the commonest
cause of morbidity and mortality in
Canadians over the age of 40 and many
of its manifestations are uniquely relieved
by operation. Since its introduction in
1968, the operation of aortocoronary by
pass has greatly increased in popularity.

SOCIETY

During 1970 this operation was performed
on almost 1000 Canadians and by the end
of 1975 over 13 000 Canadians had bene
fited from this operation— 4000 in the
last year alone. Its proven ability to alleviate
the symptoms of angina pectoris and its
expected ability to diminish the subsequent
incidence of infarction and to prolong life
have led to a demand for treatment that is
straining our present facilities. The indica
tions and benefits of this procedure will be
widened by the advances in surgical tech
nique, myocardial protection and circula
tion-assist devices detailed in the papers of
the contributing authors.
The Canadian Cardiovascular Society
appreciates the cooperation of the coeditors
and editorial staff of the Canadian Journal
of Surgery in the rapid processing of the
manuscripts and in devoting a special issue
to cardiovascular surgery.
R. J. B aird , MD, MS, FRCS[C]
Vice-president,
Canadian Cardiovascular Society.

THE ABC OF GOOD MEDICAL WRITING
That medical writing is not easy is a
truism, but physicians can take comfort in
realizing that all great writers put much ef
fort into preparing their work. It is also a
truism that the quality of much medical
writing is poor; but again, it is comforting
to know that good medical writing depends
on three simple principles only: accuracy,
brevity and clarity.
The need for accuracy should not surprise
any physician, for “truth” is an essential
quality of all good scientific work. More
practically, accuracy aids clarity, for pre-

cisely the right word helps the author com
municate his message clearly. But there are
more pragmatic reasons for a writer to be
accurate: he gains the respect of his col
leagues thereby; he assists other workers by
reporting accurately what he did and what
he found; and he certainly makes it easier
for journal editors and reviewers to react
favourably to the manuscript he submits.
With respect to brevity, the adage “Half
as long is twice as good” is a good one to
follow. But why is brevity important?
Brevity makes a writer use simple and
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direct language, which cuts through the
tangled undergrowth of opaqueness caused
by unnecessary jargon, redundancy, circum
locution and complexity. The need for
brevity forces one to eschew the lack-lustre
passive voice and the abstract noun and to
use instead the active voice and concrete
noun. The writing becomes clearer, even
more accurate, but also stronger and more
effective — and more interesting.
Finally, clarity, the sine qua non of good
writing. To get the message across it
must be clear— and to have expended time
and effort on a cherished manuscript that
is unclear is unfortunate, if not folly. Lack
of clarity breeds numerous hobgoblins—
from the reader’s becoming irritated and
frustrated because his time is wasted in
trying to understand the author to the read
er’s misinterpreting the author, perhaps, in
medicine, with unfortunate results. More
over, the first objective reader of a manu

Vol. 19

script submitted may be the journal editor
or reviewer; each abhors lack of clarity and
reacts accordingly.
Nor must one forget the reader whose
native language is not English, and the fact
that English more and more is the language
of science. Clarity then becomes doubly im
portant.
If authors knew what they wanted to say
if they do not they should not be writing
— and they could then be accurate, brief
and clear, many of the problems with
medical writing would become resolved.
True, some effort will always be necessary
in practising a skill; but medical writing
would no longer be a chore and it might
even be a pleasure for both writer and
reader.
D.

A . E. Sh eph a r d ,

MB, FRCP[C]

Scientific Editor,
Canadian Medical Association Journal.

SELF-ASSESSMENT
SESAP II QUESTION
404 . indications for coronary artery bypass grafting include
(1) disabling angina pectoris which is not relieved by medical therapy
(2) lesions demonstrated by arteriography that suggest a threat to life because of
their location or extensiveness
(3) coronary artery stenosis associated with surgically correctable valvular heart
disease or ventricular aneurysm
(4) severe ventricular dysfunction (ejection fraction of 35 per cent) associated with
coronary artery disease
For this question one or more of the answers given above is correct. Your answer should
be:
A
B
C
D
E

if only 1, 2 and 3 are correct,
if only 1 and 3 are correct,
if only 2 and 4 are correct,
if only 4 is correct,
if all are correct.

For the critique of Item 404 see page 126 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus:
Surgical Education and Self-assessment Program No. 2.)
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PROGNOSTIC SIGNIFICANCE OF ENDOCARDIAL VIABILITY
RATIO IN AORTOCORONARY BYPASS SURGERY*
] GUNSTENSEN, MB, ChB, FRCS(Edin), FRCS[C],t HUGH E. SCULLY, MD,
MSc(Med) FRCS[C], THEODORE KELLY, DP, ALLAN G. ADELMAN, MD, FRCP[C],
WILLIAM G. WILLIAMS, MD, FRCS[C], E. DOUGLAS WIGLE, MD, FRCP[C],
FACP and BERNARD S. GOLDMAN, MD, BSc(Med), FRCS[C]

*

i

>

/

Although aortocoronary bypass (ACB) for pa
tients with stable angina carries a low mortality,
some unexpected deaths do occur. Since in
patients with normal coronary arteries the endo
cardial viability ratio (EVR) can be correlated
with subendocardial perfusion, with a ratio of 0.7
or less indicating ischemia of the left ventricular
subendocardium, and since the EVR postoperatively is useful in determining the need for intra
aortic balloon pump assist (IABPA), it was de
cided to ascertain whether the EVR might have
prognostic value in patients with stable angina
scheduled for standard ACB. Three groups of
patients were studied: 50 with stable angina, 24
who had died after ACB, and 18 who required
IABPA for cardiogenic shock after surgery for
stable angina. No significant differences were
found for cardiac index, left ventricular enddiastolic pressure, left ventricular ejection frac
tion and pre- and postoperative artery scores,
but there were significant differences in the EVR
between the first and second groups and be
tween the first and third groups (P < 0.01 in
each instance). These findings suggest that the
left ventricular EVR may indeed be of prognostic
value in patients scheduled to undergo ACB and
that use of IABPA, which produces an increase
in EVR, may be useful in patients with EVRs of
less than 0.7, even if other parameters of cardiac
function are normal.
Bien que le pontage aortocoronarien soit associe a un faible taux de mortalite chez les pa
tients ayant une angine stable, quelques deces
imprevus surviennent. Comme il existe une cor
relation chez les patients ayant des arteres coronaires normales, entre I’indice de viabilite endocardiaque et la perfusion subendocardiaque, alors
qu'un indice de 0.7 ou moins indique une ischemie du subendocarde ventriculaire gauche, et

*From the departments of surgery and medicine,
University of Toronto, and the division of cardio
vascular surgery, Toronto General Hospital,
Toronto, Ont.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Montreal, Que., Oct. 2325, 1975.
fSupported by the Ontario Heart Foundation.
Reprint requests to: Dr. J. Gunstensen, 8th floor,
University wing, Toronto General Hospital,
Toronto, ON M5G 1L7.

comme la mesure de I'indice de viabilite endocardiaque pendant la periode post-operatoire
aide a determiner la necessity d'une pompe a
ballonnets intra-aortique d'appoint (destinee a
augmenter le debit sanguin au coeur et a diminuer le travail cardiaque) il a ete decide de ve
rifier si le rapport de viabilite endocardiaque
pouvait avoir une valeur pronostique chez les
patients ayant une angine stable et destines a
recevoir un pontage aortocoronarien classique.
On a etudie trois groupes de patients: 50 pa
tients avec une angine stable, 24 qui sont d e c i
des apres une operation de pontage aortocoro
narien et 18 qui ont requis une pompe a bal
lonnets intra-aortique d’appoint pour un choc
cardiogenique apres un pontage aortocoronarien
pour une angine stable. Aucune difference si
gnificative n'a ete observee en ce qui a trait
a I’index cardiaque, la pression diastolique ven
triculaire gauche finale, la fraction d'ejection
ventriculaire gauche et les scores pre- et postoperatoires des arteres coronaires, mais on a
note des differences significatives entre les
indices de viabilite endocardiaque du premier
et du second groupe et ceux du premier et du
troisieme groupe (P < 0.01 dans chaque cas).
Ces constatations suggerent que I’indice de
viabilite endocardiaque ventriculaire gauche
peut effectivem ent avoir une valeur pronostique
pour les patients devant recevoir un pontage
aortocoronarien e t que I'emploi de la pompe a
ballonnets intra-aortique d'appoint, qui produit
une augmentation de I’indice de viabilite endo
cardiaque, peut etre utile chez les patients
ayant un indice inferieur a 0.7, meme lorsque
les autres parametres de fonction cardiaque
sont normaux.

A orto co ro n a ry bypass surgery for pa

tients with stable angina is now an accept
able surgical procedure and in most centres
carries a low mortality. In October 1973
this centre acquired an AVCO intra-aortic
balloon pump and since then patients with
stable angina who had evidence of severe
left ventricular dysfunction, severe left main
coronary artery disease or severe triple
vessel disease have undergone aortocoronary
bypass with prophylactic preoperative intra
aortic balloon pump assist (IABPA) with
95% survival.1’ 2 A further 352 patients
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with stable angina underwent surgery in the
normal manner but 18 (5.1%) have required
IABPA for the control of cardiogenic shock
in the postoperative period and of these 12
(67% ) have survived. That cardiogenic shock
should have developed in so many patients
was somewhat disconcerting, since routine
preoperative investigations should have
identified those who would benefit from
prophylactic IABPA. Preliminary investiga
tion of the 18 patients revealed that 11
(61% ) had a low endocardial viability ra
tio (EVR) as the only gross hemodynamic
abnormality.
The EVR (obtained by dividing the dia
stolic pressure time index by the tension
time index [DPTI/TTI]) is correlated with
subendocardial perfusion in patients with
normal coronary arteries,;i and a ratio of
0.7 or less indicates ischemia of the left ven
tricular subendocardium. The postoperative
estimation of the EVR is of value in deter
mining whether patients with low cardiac
output postoperatively will benefit from
IABPA,4 which improves the EVR (Fig. 1)
and thus improves the circulation to the left
ventricular endocardium.
A precise estimation of the true EVR is
not possible in patients with coronary artery
disease because the decrease in pressure
across an individual area of stenosis in a

100r
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coronary artery can not as yet be measured.
As use of IABPA increases the EVR and
as, prophylactically, it results in improved
survival when compared with its use for
postoperative cardiogenic shock, it seems
pertinent to ascertain whether the EVR has
any prognostic value in patients with stable
angina who are scheduled for standard aor
tocoronary bypass.

I '
■4

Patients and M ethods

The patients in this series were of three
groups: group 1 comprised 50 randomly
selected patients with stable angina who
survived an aortocoronary bypass proce
dure in 1971 and 1972; group 2 included 24
patients who died after aortocoronary by
pass from June 1969 to October 1973, dur
ing which period the total number of patients
thus treated was 475; and group 3 com
prised 18 patients who required IABPA
for postoperative cardiogenic shock after
aortocoronary bypass for stable angina.
Variables reflecting left ventricular func
tion and coronary artery disease that were
examined were the coronary artery score,
cardiac index (Cl), left ventricular ejection
fraction (LVEF) and EVR. The coronary
artery score was estimated for each vessel
as a modification of the Friesinger tech
nique" as follows: a score of 1 was recorded

'

4

------ L V PRESSU RE
H 3

TTI

(SY ST O L E)

DPTI

( D IA S T O L E )
t-

4

EVR = 0-67
IABP
S J E H S

OFF

IABP

ON
m y o c a rd K ly g e n

*

■
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of EV R in G roups 1, 2
for multiple, 50% occlusions; 2, for proxi TABLE II.—C omparison
and 3
mal occlusion of 50 to 75% ; 3, for proxi
Group
mal occlusion of 75 to 95% or for multiple
occlusions of 50 to 75% ; 4, for proximal
1
2
3
{n = 50) (n = 24) (n = 18)
occlusion of 90 to 99% or for multiple oc
clusions of 75 to 95% ; and 5, for proximal Mean EV R*..........
0.98
0.78
0.82
occlusion of 100%. These scores were then No. of patients
6
11
11
with EVR < 0.7
summed to provide a total preoperative
*Differences
between
groups
were
significant
for
1
score; bypass into a vessel diminished the
v. 2 (P < 0.01) for 1 v. 3 (P < 0.01); difference be
score appropriately and the total postoper tween 2 and 3 was n ot significant (P < 0.7).
ative score was also added. The Cl was
calculated by the Fick technique and the TABLE III.—C omparison o f H emodynamic D ata
left ventricular end-diastolic pressure for P atients w it h EVR B elow 0.7 and A bove 0.7
(LVDEP) was recorded during left heart
EVR
catheterization. The LVEF was calculated
< 0.7
> 0.7
by an estimation of the difference between Variable
(mean, 0.59) (mean, 1.03)
the end-diastolic volume and end-systolic
Coronary artery
volume in a single-plane right anterior
10.4
9.6
score....................
3.07
2.71
oblique projection. The EVR was calculated CI, I/min-m2..........
12.0
11.2
mm Hg . .
from the tracings obtained from withdrawal LVEDP,
56.2
60.2
LVEF, % ...............
of the catheter from the left ventricular ca
vity into the aorta after left ventricular an
D isc u ssio n
giography.
Evolving indications for the prophylactic
use
of IABPA include relief of ischemia
R esults
in acute coronary artery insufficiency0 and
Mean values for coronary artery score,
support of patients undergo
cr, LVEDP and LVEF for the three groups cardiovascular
ing aortocoronary bypass or valve replace
are given in Table I. No significant differ ment in the presence of poor left ventricu
ences were noted between the groups for lar function,2 patients with left main-stem
any of the variables.
lesions, or patients with both valve dis
The mean values for EVR are presented ease and coronary artery disease requiring
in Table II, together with statistical find a concomitant surgical procedure. Never
ings. An EVR of less than 0.7 was not nec theless, in spite of all these precautions,
essarily associated with other abnormalities. cardiogenic shock occasionally develops at
The values for coronary artery score, Cl, the end of what should have been a straight
LVEDP and LVEF for patients with an forward saphenous vein bypass graft pro
EVR of 0.7 or less (mean, 0.59) and those cedure. The results of our study show that a
with an EVR of greater than 0.7 (mean, low preoperative value for left ventricular
1.03) are displayed in Table III. None of EVR will be recorded for an undue num
the differences in these values are signifi ber of these patients. It therefore seems
cant.
logical that the estimation of the EVR
should be part of routine preoperative in
TABLE I. —H emodynamic D ata for G roups 1, 2
vestigation
of the patient undergoing an
and 3
aortocoronary bypass procedure. When in
Group
vestigation reveals a low EV R the prophy
lactic use of IABPA should be considered.
~1
2
3

Variable
Coronary artery
score (mean)
Preoperative. . . .
Postoperative. . .
Cl, I/min-m2.........
LVEDP, mm Hg. .
LVEF, % ...............

(n = 50) (m= 24) (n = 18)
R eferences

9
3.2
2.8
10.4
60.9

11
4.5
2.7
11.4
58.6

10.5
4.2
3.0
13.7
55.2

1. G oldman BS, W alker P, G un sten sen J, et
al: Intra-aortic balloon pump assist: ad
junct to surgery with left ventricular dys
function. Can J Surg 19: 128, 1976
2. Scully HE, G unstensen J, W illiam s W G, et
al: Increasing survival in surgical man-

96

THE CANADIAN JOURNAL OF SURGERY

agement of complicated acute coronary
insufficiency. Paper presented at annual
meeting of Canadian Cardiovascular So
ciety, Montreal, Que., Oct. 23-25, 1975
3. Buckberg GD, F ixler DE, A rchie JC, et al:
Experimental subendocardial ischemia in
dogs with normal coronary arteries. Circ
Res 30: 67, 1972
4. P hilips PA, M arty AT, M iyamoto AM:
Clinical method for detecting subendo
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cardial ischemia after cardiopulmonary
bypass. J Thorac Cardiovasc Sure 69: 30,
1975
5. F riesinger GC, P age EE, Ross RS: Prognos
tic significance of coronary arteriography.
Trans Assoc Am Physicians 83: 78, 1970
6. G old HK, L einbach RC, Sanders CA, et al:
Intraaortic balloon pumping for control
of recurrent myocardial ischemia. Circula
tion 47: 1197, 1973

TRIPLE-VESSEL CORONARY ARTERY DISEASE: EFFECT OF
REVASCULARIZATION ON LATE SURVIVAL*
W. J. KEON, MD, FRCS[C], P. BEDARD, MD, FRCS[C], Y. AKYUREKLI MD
FRCS[C], M. P. BRAIS, MD, FRCS[C] and J. PORTER, MD
*
Of the first 600 patients to receive aorto
coronary bypass grafts 383 had three dis
eased vessels, and of them 36 ( 9 % ) have died:
20 (5 % ) in hospital and 16 (4 % ) late. In 10 of
those who died, ventricular function was normal,
class I or class II and in the other 26 function
was class III or class IV. For all ventricular
classes except class IV, improvement in myo
cardial blood flow with operation was consider
ably lower than average in those who died. The
leading cause of late death was congestive heart
failure followed by myocardial infarction, and
then by other cardiac complications. Of patients
with good (normal, classes I or II) ventricular
function, 3 .5 % died during a mean follow-up
period of 27 months; and since, according to
published reports, 1 % of patients with triple
vessel disease without surgical intervention die
each month, the data from this study suggest
that survival in this group is improved by 23.5%.
This study also shows that in patients with triple
vessel disease and good ventricular function,
adequate coronary artery bypass operations (i.e.,
placement of three grafts or more) improves sur
vival.
Des 600 premiers patients a recevoir un
pontage aortocoronarien, 383 avaient une at
teinte de trois vaisseaux, et de ceux-ci 36 ( 9 % )
moururent: 20 ( 5 % ) a I'hopital et 16 ( 4 % ) ulterieurement. Dix de ceux qui sont morts presentaient une fonction ventriculaire normale, classe

*From the University of Ottawa cardiac unit,
Ottawa Civic Hospital, Ottawa, Ont.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Montreal, Que., Oct 2325, 1975.
Supported by the Ontario Heart Foundation.
Reprint requests to: Dr. W. J. Keon, University of
Ottawa cardiac unit, Ottawa Civic Hospital 1053
Carling Ave., Ottawa, ON K1Y 4E9

I ou classe II, et les 26 autres appartenaient aux
classes III et IV. Pour toutes les classes ventriculaire, sauf pour la classe IV, (’amelioration du
debit sanguin myocardique qui suivit I’operation
fut considerable merit inferieure a la moyenne
chez ceux qui moururent. La principale cause des
deces survenant tardivement fut I'insuffisance
cardiaque suivie d'un infarctus du myocarde, et
ensuite d'autres complications cardiaques. Chez
les patients presentant une bonne fonction ventriculaire (normale, classe I ou II), 3.5% mou
rurent pendant une periode de post-observation
moyenne de 27 mois; et comme, d'apres les
observations publiees, 1% des patients qui ont
une atteinte de trois vaisseaux et qui ne subissent pas d’intervention chirurgicale meurent
chaque mois, les donnees de cette etude suggerent que la survie de ce groupe a ete amelioree
de 23.5%. Cette etude montre aussi que chez
les patients ayant une atteinte de trois vais
seaux et possedant une bonne fonction ventriculaire, une operation de pontage aortocoronarien adequate (i.e. la pose de trois greffons ou
plus) ameliore la survie.

C oronary artery bypass grafting, a rela

tively new operative technique that has
gained popularity, is now the most widely
used surgical form of treatment for ischemic
heart disease.1 Bypass grafting operations
have not been performed for long enough
to permit reliable assessment of their ef
fectiveness to be made and, at present, car
diac surgeons can only present their past
experience and theorize that this experi
ence indicates future trends.
The use of bypass grafts for triple coro
nary vessel disease has been little investi
gated. Results in a large series have been
analyzed by workers from the Cleveland
Clinic, where, of 397 patients with three
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diseased vessels and who received three by
pass grafts, 10 died in hospital and 11 died
later (mortality, 5.2% ).2 Others have re
ported hospital mortalities of 5.4% and
8 % ,:!- 4 and one group, using life-table
analysis, estimated a survival of 96% over
4 years in patients who did not have con
gestive heart failure preoperatively or who
did not undergo auxiliary procedures such
as valve replacements.'' And for a group of
patients evaluated 2 years after operation,
survival was 88% in patients with normal
ventricles and 71% in those with abnormal
ventricular function.6
In this paper we report the results of by
pass grafts for triple-vessel disease in our
first 383 consecutive patients.
P atients and O per a tiv e P rocedures

Between April 1970 and March 1974,
600 patients underwent operations in the
University of Ottawa cardiac unit. Of these
TABLE I.—Condition of P atients who U nder
went E mergency Operation
Preoperative condition

No. of
patients

No. of
deaths

Cardiogenic shock.........
Acute myocardial
infarction...................
Preinfarction angina. . .
Angiographic
emergency..................

3

2

13
26

2
2

2

0

Total.......................

44

6

TABLE II.—M ortality

of

97

patients 383 were defined as having triple
coronary vessel disease— that is, occlu
sion or stenosis of at least 70% in the right,
anterior descending and circumflex arteries.
There were 25 women and 358 men; their
mean age was 49 years.
Before operation 40 of these patients
were asymptomatic, 105 had class II an
gina, 140 were considered to have class III
angina and 98 were graded as having class
IV angina.
An operation was performed under
emergency circumstances in 44 patients.
The preoperative condition of these patients
and the mortality is given in Table I. Re
sults of operation in these patients and in
those who underwent operation electively
are summarized in Table II.
The types of procedures performed and
the associated mortalities are set forth in
Table III. The 383 patients received a to
tal of 1009 bypass grafts. A single graft
was placed in 49 patients, double grafts in
87, triple in 205, quadruple in 39 and quin
tuple in 3. In 220 patients all three diseased
vessels were grafted, in 111 two vessels
were grafted, and in 52 only one vessel was
grafted.
R esu l t s

Of the 383 patients who were operated on
for triple-vessel disease, 36 had died by
March 1974, 20 (5%) at operation or in
E lective

and

E mergency P rocedures
No. (and %) of deaths

IVU . UJ
patients

Hospital

Elective.............................................................
Emergency.......................................................

339
44

16 (4.7)
4 (9.1)

14 (4.1)
2 (4.5)

30 (8.8)
6 (13.6)

Total.........................................................

383

20 (5.2)

16 (4.2)

36 (9.4)

Urgency of operation

TABLE III.—T ypes

of

P rocedures

Grafts alone.............................................................
Grafts and implants................................................
Grafts and aneurysmectomies..............................
Grafts and valve replacements.............................
Grafts, implants and aneurysmectomies.............
Grafts and repair of ventricular septal defects. .
Grafts, implant and valve replacements.............
Total.................................................................

and

Late

Total

A ssociated M ortality
No. of
patients

No. (and %)
of deaths

199
138
22
7
15
1
1

18 ( 9)
11 ( 8)
4 ( 18)
2 ( 28)
0 ( 0)
1 (100)
0 ( 0)

383

36

98

MORTALITY
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Fig. 1.—Increase in mortality (in percent) ac
cording to decrease in ventricular function.

hospital and 16 (4%) after discharge from
hospital.
Mortality was correlated with preoper
ative ventricular function (Fig. 1). Among
the 137 patients with normal ventricular
function 4 died, but otherwise mortality was
correlated with poor ventricular function.
None of the 61 patients with class I ventri
cular function died, either in hospital or
after discharge. Six of the 107 patients
with class II function died, 3 in hos
pital and 3 later. Among the 43 patients
with class III ventricular function 8 (20%)
have died, 6 early and 2 late. The highest
number of deaths was among patients with
class IV function, of whom 18 of 40 pa
tients have died (10 of whom died late).
Late death occurred at an average of 9
months after operation. The causes are listed
in Table IV. The most frequent causes of
late death were congestive heart failure,
in 5 of the 16 patients, and myocardial in
farction in 4 patients; the cause of death

was unknown in 3 patients and varied in
the remainder. The number of bypass grafts
received was calculated (Table IV) and it
was found that only 3 of the 16 patients
received three grafts. The total increase in
myocardial flow was also determined: in the
majority of patients the increase was much
below the normal increase in myocardial
blood flow. We also calculated that for our
100 most recent patients, the average in
crease in myocardial flow was 175 ml and
we found that in only 3 of the patients who
died late was this average exceeded and
that they were all patients with class IV
ventricular function.
Class of angina was determined I year
after operation. Analysis showed that 249
patients had become asymptomatic and that
80 had class II angina. There were 21 pa
tients in whom serious angina persisted —
14 with class III angina and 7 with class IV.
At 1 year, 33 patients had died; the other
3 died later.
D iscussion

One of the primary causes of death in
triple-vessel disease among surgical patients
appears to be inadequacy of the operation.
We believe that for an operation to be con
sidered adequate three or more bypass grafts
should be performed and that myocardial
blood flow should increase by at least 150
ml. With respect to the patients who died
in hospital, an average of 2.5 grafts were
placed, whereas with respect to the patients
who died late an average of only 1.84 grafts
were placed. The majority of patients who
received fewer than three grafts were oper
ated on during the first 2 years of our ex-

TABLE IV.—F indings Associated
Ventricular
function class

II
III
IV

with

L ate D eaths

N°- of
patients____________ Cause of death

Average no.
of grafts

Total increase in
myocardical flow, ml

Unknown

2

64

Myocardial infarction
Congestive heart failure
Myocardial infarction
Unknown
Congestive heart failure
Myocardial infarction
Arrhythmia
Pulmonary embolism
Cardiorespiratory failure
Cardiac arrest
Unknown

1
1.5
1
2
2
1.5
1
2
3
3
3

Normal
I
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0
1
2
1
1
3
2
I
1
1
1
1

*ND = not determined.

ND*
60
ND
ND
100
95
75
330
ND
180
225
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perience in performing bypass grafts, when
we were more cautious about doing multi
ple grafting. We now do as many bypass
grafts as we believe to be needed; in the
most recent 50 patients with triple-vessel
disease treated surgically an average of four
grafts were performed and among them
there were no early or late deaths.
Calculation of increase in myocardial
blood flow revealed that the average ranged
from 141.54 ml/min in patients with class
I ventricular function to 178.66 ml/min
in patients with class IV function. A com
parison of average graft flows in the sur
viving and deceased patients (Table V)
showed notable differences: in all but those
with class IV ventricular function the blood
flow was considerably higher in the sur
vivors than in the nonsurvivors. These find
ings indicate that an inadequate operation,
as evidenced by a low increase in blood
flow or grafting of fewer than three vessels,
is a prognostic indicator of mortality in
triple-vessel disease.
Ventricular function is also a determin
ant of mortality. As Fig. 1 illustrates, mor
tality increases according to the decrease in
ventricular function; the curve rises much
more sharply with the class of ventricular
function: 20% of patients with class III
function and 45% of those with class IV
function have died. Six of the patients with
class III function underwent emergency
operations; three died at operation and three
survived.
There have been several reports on med
ical treatment of patients with triple-vessel
disease that have disclosed a resulting mor
tality of 10 to 20% per year depending on
the medical condition of the patients at the
time of angiography. The poorest results
were in a group studied by Slagle and asso
ciates : 7 all the patients had congestive heart
TABLE V.—A verage I ncreases of M yocardial
B lood F low in Survivors and N onsurvivors
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failure and previous myocardial infarction,
and an annual mortality of 20% was found
in this group. Bruschke, Proudfit and
Soness and Lichtlen and Moccetti0 studied
a randomized group that included patients
with congestive heart failure and both re
ported annual mortalities of 10 to 11%.
Webster, Moberg and Rincon10 excluded
patients with congestive heart failure from
angiographic study. In spite of this exclu
sion, the annual mortality rate remained
at 10 to 11% . Oberman and associates11
divided their patients into a group of those
with congestive heart failure and those
without and reported a 24% annual m or
tality in the first group and 12% in the
second.
Our patients with good ventricular func
tion (i.e., normal function or class I or II
function) could most clearly be compared
with the group without congestive heart fail
ure reported by Oberman and associates11
for whom there was a 12% annual mortali
ty rate. At a mean time of 27 months after
operation, 6 (1.5%) of our patients with
good ventricular function had died in hos
pital and 8 (2% ) later. Since 1% of the
patients in the nonsurgical group of Ober
man and associates died each month, 27%
of them would be dead at 27 months, in
contrast with only 3.5% of our surgical
patients (Fig. 2). We believe that coronary
artery bypass grafting offers a better prog
nosis for patients with triple-vessel disease
than does medical treatment alone.
To learn whether revascularization im1009080“
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Increase in myocardial
blood flow, ml/m in
V e n t r i c u l a r ---------------------------------function
Non
class
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Normal.....................
I
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..................

176.16
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Fig. 2.—Prognosis of patients with triple-vessel
disease: surgical and nonsurgical patients. Morta
lity for patients with good ventricular function
treated surgically for triple coronary artery disease
was 3.5% at mean time of 27 months after oper
ation; for nonsurgical patients in group studied by
Oberman and associates11 mortality was 1% per
month.
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an em erging problem
“Bacteroides species are often over
looked as a cause of serious infec
tion both by clinicians and micro
biologists. They are most commonly
associated with intra-abdominal
and pelvic sepsis following gastro
intestinal surgery.”

“Our experience with this series of seriously
ill patients provides clinical confirmation toA
complement recent in vitro evidence that
clindamycin is the antibiotic of choice for
use in bacteroides infections. Not only was*'
the response in 17 of the 18 patients favour
able, but in several it was dramatic.”
''

Tracy, 0 .,e t al.(29 Jan.’72).
Brit. med. J.,p. 280.

Haldane, E.V. and van Rooyen.C.E. (1972).
C.M.A.J.,p. 1177.
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.bacteroides infection

• I.M. injection or I.V. infusion
achieves prompt and high peak
r serum levels of active clindamycin
• well tolerated locally and sys•^tem ically following I.M. injection
„ jor I.V. infusion
'’
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treatment o f certain infections due to anaerobic bacteria, including
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Clostridium species and microaerophilic streptococci. It is also in
dicated in infections due to sensitive Gram-positive organisms, par
ticularly staphylococci, streptococci and pneumococci. As with all
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Adults:
Intramuscular-600 to 2400 mg*/day in 2, 3, or 4 equal doses. In
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Significant diarrheaoccurringuptoseveral weeks post-therapy should
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proved the patients’ quality of life as well
as increasing their chances of survival, we
assessed the level of rehabilitation 1 year
after operation. Information was obtained
on 321 of the 383 patients; 70% were work
ing, 10% were not working, 3% were
working part-time, 5% had retired, and
12% were dead. We hold that surgical in
tervention rehabilitates a large number of
patients with triple-vessel disease so they
can lead a productive life.
C onclusions

Surgical treatment appears to be a more
effective means of therapy than medical
treatment, as evidenced by our experience.
Of our patients, 3.5% died during a period
in which 27% would have been expected to
die with medical management alone. Qual
ity of life of these patients is greatly im
proved by myocardial revascularization;
70% of them were working 1 year after
operation. The major prognostic indicators
in determining survival are the quality of
ventricular function preoperatively, the de
gree of improvement in total myocardial
blood flow, and the distribution of flow
achieved by operation. Intraoperative meas
urement of improved myocardial blood flow
with operation should be an essential part of
the procedure. Patients with normal ventri
cular function and triple-vessel disease have
a low operative mortality and excellent late
survival.
We thank Mrs. Elizabeth Masson for her help
in preparation of this manuscript.
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USE OF A MEMBRANE OXYGENATOR
FOR OPEN-HEART SURGERY IN INFANTS*
D. A. MURPHY, MD, FRCS[C], D. A. GILLIS, MD, FRCS[C], FACS
and H. LAU MD, FRCS[C]
Because use of the bubble oxygenator during
open-heart surgery is associated with com
plications such as hemolysis, pulmonary in
sufficiency and oliguria, a membrane oxygenator
was used in conjunction with hypothermia in 37
infants. The main features of the oxygenator are
gravitational blood flow, oxygenation into an air
less, collapsible blood reservoir, low-flow roller
pump flow back to the patient, accurate deter
mination of flows and careful use of a heat ex
changer. Gas flow (98% oxygen, 2% carbon
dioxide) for the unit of 2 m is maintained at 3
to 4 //m in . Specific precautions are taken to
ensure absence of bubbles. Three prime solu
tions are used, the final one having an osmola
lity of 381 mOsmol and containing 129.9 meq of
sodium, 3.8 of potassium and 94.0 of chloride
and 2001 m g /dl of glucose. Six patients died, but
none of the deaths could be directly related to
the use of the oxygenator. Respiratory complica
tions were minimal, as were other complications.
The technique is reliable in oxygenating blood
in an extracorporeal circulation, but further fami
liarity with the membrane oxygenator for use in
open-heart surgery in infants is desirable before
firm conclusions can be drawn as to its value.
Parce que I’emploi de I'oxygenateur a bulle
pendant les operations a coeur ouvert est associe a des complications telles que I’hemolyse,
I'insuffisance pulmonaire et I’oligurie, un oxygenateur a membrane a ete utilise en associa
tion avec I'hypothermie chez 37 nourrissons. Les
caracteristiques principales de cet oxygenateur sont un ecoulement du sang par gravita
tion, I’oxygenation dans un reservoir a sang
compressible, sans air, un retour du sang
au patient au moyen d’une pompe peristaltique a faible debit, une determination pre
cise des debits et ('utilisation soigneuse d'un
echangeur de chaleur. Le courant de gaz (oxygene 98% et gaz carbonique 2% ) pour I'unite
de 2 m est maintenu a 3 a 4 //m in. Des pre-

*From the department of surgery, division of
cardiovascular surgery, Dalhousie University,
Halifax, NS.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Montreal, Que., Oct. 2325, 1975.
Supported by the Nova Scotia Heart Foundation.
Reprint requests to: Dr. D. A. Murphy, Division
of cardiovascular surgery, The Izaak Walton
Killam Hospital for Children, 5850 University
Ave., Halifax, NS B3J 3J6.

cautions particulieres sont prises afin de s'assurer de I'absence de bulles. Trois solutions
d’amorpage sont utilisees dont la derniere a
une osmolalite de 381 m osmole et contient
129.9 meq de sodium, 3.8 de potassium et 94.0
de chlorure et 2001 m g/dl de glucose. Six
patients sont morts, mais aucun deces n’a pu
etre relie directement a I’emploi de I’oxygenateur. Les complications respiratoires ou autres furent sans importance. Pour I'oxygenation du sang en circulation extracorporelle, la
technique demeure fiable mais il est souhaitable qu'une plus grande experience soit
acquise dans (’utilisation de I’oxygenateur a
membrane en chirurgie a coeur ouvert chez les
nourrissons avant que des conclusions d efi
nitives puissent etre tirees sur sa valeur.

A variable degree and incidence of hemo
lysis, pulmonary insufficiency and oliguria
is accepted by most surgeons as the price of
extracorporeal circulation in small infants.
These complications have been largely mini
mized by using a shorter extracorporeal
circulation time and techniques of moderate
surface hypothermia, profound hypother
mia and circulatory arrest, and lower bypass
flow rates. In most centres the bubble oxy
genator is an integral part of the extracorpo
real circuit and these complications persist.
We have recently seen two cases of lethal
hyperkalemic cardiac arrest occurring with
in the first 24 postoperative hours result
ing from hemolysis, and because of this ex
perience we decided to substitute a mem
brane oxygenator in the extracorporeal
circuit in all patients weighing less than 10
kg in an attempt to minimize these com
plications. The purpose of this communica
tion is to describe our experience with such
an oxygenator.
P atients

and

Methods

The membrane oxygenator was used in
37 patients, whose average age was 9.4
months (range, 3 days to 24 months) and
average weight was 6.01 kg (range, 2.6 to
9.8 kg). The perfusion time averaged 82
minutes (range, 14 minutes to 4 hours 11
minutes). The diagnoses and results of opera
tion are listed in Table I.
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T A B L E I.— D iagnoses and R esults of O p e n H eart S urgery U sing M embrane O xygenator

Diagnosis
Ventricular septal defect
Tetralogy of Fallot and
complex..........................
Transposition....................
Primum atrial septal
defect..............................
Atrioventricular canal. . . .
Pulmonary stenosis..........
Aortic stenosis...................
Truncus arteriosus............
Hypoplastic left h e a rt.. ..
Miscellaneous....................

No. of
patients

No. of
hospital
deaths

12

0

4
6

1

4

0
0
0
0

2
1
2
2

1
3

1

2
1

1

Some form of induced hypothermia was
used in all patients. In most, anesthesia was
begun with ketamine to facilitate insertion
of arterial and venous pressure monitoring
catheters, after which either halothane or
nitrous oxide (50%) and curare were ad
ministered. Surface hypothermia was in
duced either by placing small ice packs
around the patient or by floating the pa
tient on an ice bath while the surgeon was
scrubbing. In three infants with complicated
lesions surface cooling alone was used to
obtain a sufficiently low core temperature
for circulatory arrest without bypass, but
in 17 of the 37 infants varying periods of
cardiopulmonary bypass were instituted in
order to control the circulation and allow
surgical repair to be done under optimal
conditions.
Priming and Bypass Technique
Circuit components.— The circuitry is
demonstrated in Fig. 1. The membrane oxy
genator rests 7.5 cm off the floor on a low,
operating-room foot platform. Blood flow
through the membrane is gravitational and
the oxygenated blood rises into an airless,
Edwards collapsible blood reservoir.* This
reservoir is approximately 30 cm above the
top of the oxygenator so that there is a suf
ficient resistance in the membrane blood
outlet to distend the sandwiched membranes
and prevent blood streaming between the
membrane sheets; it is supported by a sim
ple, but accurate, tension-spring scale so
that the volume of blood within it can be
monitored. A low-flow roller pump (maxEdwards Laboratory, Santa Ana, CA.

Fig. 1.—Circuitry for membrane oxygenator.
Venous and cardiotomy tubing is indicated by
dotted lines.

imum flow, 1 //min)* returns the blood to
the patient via an aortic root cannulation.
Precise flows are determined with the aid
of a Statham electromagnetic flow probe
(0.625 x 0.625 cm) in the circuit. The tub
ing throughout is of Tygon (internal diame
ter, 0.625 cm). A Sarnsf miniprime heat
exchanger is placed on the venous outflow
from the patient so that, should bubbles
form because of excessive temperature
changes, they are likely to be trapped in the
oxygenator or the reservoir; similarly, any
air coming down the venous line would be
trapped in the heat exchanger. The Travenol
disposable oxygenator was used initially;
however, the Sarns metal heat exchanger has
now been substituted because of its superior
efficiency.
The cardiotomy suction return enters the
circuit through a 0.625-cm T-piece at a
point just before the membrane oxygenator.
All prime solutions enter via this system.
Connectors in the circuit are plastic or
metal. A coil of the sterile tubing, which will
become the arterial and venous lines, is
placed on a sterile side table, adjacent to
the operating room table, and is covered
with double drapes. This allows the per
fusionist to rinse, debubble and fully prime
all the membrane and tubing while the sur
geon is preparing the surgical field. The
former procedure takes time (up to 1 hour)
and should not be rushed.
Operation of bypass.— The gas flow for
*American Optical Co., Spring Garden Rd.,
Halifax, NS.
fErika Laboratories, 53 Rancliffe Rd., Oakville,
ON.
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a unit of 2 m2, consisting of 98% oxygen
and 2% carbon dioxide, is started and
maintained at 3 to 4 //min. A first prime
of 1500 ml of 5% dextrose and water, con
taining 15 000 units of heparin, is added
through the Bentley reservoir. The roller
pump is operated at the maximum rate (1
//min) while most of the large bubbles are
evacuated from the membrane by tilting
the unit in all directions and gently thump
ing the unit with the open palm. This takes
approximately 20 to 25 minutes.
The rinse is then drained out of the arte
rial Edwards reservoir with the pump still
in operation. This rinse is slowly pushed out
by a second rinse that comprises 1500 ml of
5% dextrose and water without heparin,
with 100 ml sodium-free human albumin.
The latter coats the plastic surfaces and
diminishes platelet adherence. The recir
culation is continued and tiny bubbles will
be evacuated at this time. Another 20 min
utes is required for this step.
The pump is decreased and as much of
the second prime is drained from the reser
voir as possible without letting in any air.
Then the final prime, which helps push out
the second liquid rinse, is added, consist
ing of 2 units of fresh (3 days) citratephosphate-dextrose
reconstituted
whole
blood, to which has been added 1.5 ml of
1% magnesium sulfate and 20 ml of 20%
mannitol. This blood prime is slowly recir
culated and the membrane is now left un
disturbed for the duration of the case. The
final prime constituents are listed in Table
II.
TABLE II.—Constituents

of

F inal P rime

Constituent

Content

Sodium, m eq......................................
Potassium, m eq.................................
Chloride, meq....................................
Osmolality, mOsmol.........................
Glucose, m g/dl..................................
Uric acid, m g.....................................
Hemoglobin, g /d l..............................
Hematocrit, % ..................................

129.9
3.8
94.0
381
2001
2,78
9.1
24

Two observations were made from these
measurements. The sodium concentration
in the final prime is very variable and prob
ably represents the size of the membrane
and the volumes of the rinse. It was never
greater than 144 meq, but on three occa
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sions was less than 118 meq, though no
ill effects resulted. On occasion also, the
prime plasma hemoglobin concentration was
greater than the postbypass value. The total
volume of the circuit of 2 m'-’ is approxi
mately 1000 ml.
Once the infant has been prepared and
draped, the sterile covering over the arterial
line is removed and brought to the operat
ing room table, where it can be divided in
preparation for bypass.
R esu lts

Deaths
There were six deaths in this group of
patients. One patient with a tetralogy of
Fallot and Ebstein’s anomaly had previous
ly undergone three operations— a left Bla
lock shunt, a Waterston shunt and an open
infundibulectomy in the first 12 months of
life. At 24 months of age, severe cardiomegaly and tricuspid regurgitation devel
oped, and total correction was urgently re
quired. She underwent closure of atrial and
ventricular septal defects, infundibulectomy,
tricuspid valvular annuloplasty and closure
of the Waterston shunt. The early part of
the operation was complicated by hypo
tension and bradycardia, necessitating rapid
commencement of cardiopulmonary bypass
via the right atrium and the right common
iliac artery. Bradycardia and hypotension
at approximately 20 minutes after cessation
of bypass were treated successfully, but she
died approximately 1 hour later, in the in
tensive care unit, of low cardiac output.
Despite more than 4 hours of bypass time
and 22 minutes of circulatory arrest, the
patient’s plasma hemoglobin concentration
was 100 mg/dl at the end of operation.
One infant died 24 hours after a Mustard
repair. This patient underwent a Dacron
patch enlargement of her new left atrium.
However, it was not preclotted and as by
pass was being discontinued it was neces
sary to transfuse 3 units of old acid-citratedextrose blood without the use of a Micro
pore transfusion filter. The pulmonary in
sufficiency and terminal supraventricular
tachycardia in this patient could have been
related to use of the membrane oxygenator,
but it is more likely that they were related to
the sequelae of controlling the bleeding
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from the patch and the episode of hypoten
sion.
Two infants underwent total correction
of type 1 truncus arteriosus. The first, a
6-week-old infant, died approximately 6
hours after correction, of pulmonary ede
ma, pulmonary hemorrhage and low car
diac output. The second, a 2-month-old in
fant, underwent total correction, consisting
of closure of ventricular and atrial septal
defects with insertion of a nonvalved, 10mm Dacron graft from the right ventricle to
the divided pulmonary artery. Extubation
was effected shortly after arrival in the in
tensive care unit and an excellent cardio
pulmonary status was maintained, with nor
mal blood-gas and biochemical values prior
to sudden cardiac arrest approximately 10
hours after surgery. The autopsy revealed
no particular cause for the cardiac arrest.
One critically ill infant, in whom cardiac
arrest had occurred in the cardiology lab
oratory, underwent total correction of a
long, preductal coarctation and closure of
atrial and ventricular septal defects. This in
fant could not support an adequate circula
tion following termination of bypass.
The last infant, with hypoplastic left
heart syndrome, died 36 hours after opera
tion with low aortic pressure and anuria.
The operation had consisted of creation of
a large window between ascending aorta
and main pulmonary artery, distal main
pulmonary artery banding, duct ligation and
atrial septectomy.
Respiratory Complications
Apart from these six patients, the remain
der had minimal respiratory problems. Most
(18) were either extubated in the operating
room or on arrival in the intensive care unit;
11 were extubated within 24 hours, 2 with
in 48 hours, and 1 at 3 days. Late pul
monary complications, such as increased
secretions and lobe collapse, developed in
six patients, but none required reintubation
or tracheostomy.
Renal Function
Not one infant had hemoglobinuria and
only one had oliguria, attributable to poor
distal aortic perfusion (hypoplastic left
heart). All other infants initially voided
large quantities of clear urine.
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Blood Values
Platelet counts were initially performed
routinely, but discontinued as the mean for
a group of 14 patients was 138.5 x 10 s*//
(range, 57 to 289 x 10,J/0- Bleeding aver
aged 29 m l/kg body weight for a 48-hour
period, though this was extremely variable
depending on the complexity of the opera
tion. In three infants re-exploration was re
quired for bleeding; specific bleeding points
were found in all.
Mean plasma hemoglobin concentrations
measured from the pump at the end of by
pass were 30.3 mg/dl (n = 33).
D iscussion

The evidence that membrane oxygenators
are superior to bubble oxygenators for short
term, extracorporeal circulation, remains
scant. This can largely be attributed to our
inability to identify specific alterations in
the blood that could be blamed for the mor
bid and clinical changes observed in pa
tients following cardiopulmonary bypass
with bubble oxygenators. Although many
alterations in blood composition have been
observed, the identification of a single fac
tor, or of several factors, that might clearly
be the cause of diminished pulmonary sur
factant, for example, has yet to be made.
Changes have been observed in the
plasma of blood exposed directly to a gas
phase,1' 8 but whether these changes speci
fically cause the clinical picture of oliguria
or pulmonary insufficiency is not known.
Dobell and colleagues,3 in an ingenious ex
periment, demonstrated the lethal effect of
perfusing small dogs with plasma that had
been recirculated in a screen oxygenator
circuit. The protective effect of interposing
a Teflon membrane oxygenator was demon
strated in another experimental model that
was similar except that whole blood was
used. The specific alteration in the plasma
causing the animals’ deaths and the exact
physiologic sequelae were not identified.
This observation needs further investiga
tion.
Not having a specific change to look for,
most investigators measure the traumatic
effect on erythrocytes and platelets. Plate
let counts and function have been compared
in membrane and bubble oxygenators,4- 5
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and it is clear that both red cell and platelet
function are better preserved' in a mem
brane system. Particle counts0-8 in the arte
rial inflow line of patients undergoing car
diopulmonary bypass have been greatly
diminished in membrane oxygenators, and
cerebral function is said to be superior. Pul
monary function, on the other hand, as
measured experimentally in animals, is not
significantly different9 between the two
types of oxygenators.
No one could argue that the observed
hematologic changes are useful to the body,
but their clinical importance to the cellular
and subcellular systems of the body is not
clear. It is just not known how much whole
blood damage is clinically tolerable. The
problem has been summarized by Peirce:10
“standard tests [for measurements of these
changes] are not available and there is
much room for improvement in methods”.
Without specific measurements, evalua
tions must be based on testimonials4’ 11-13
such as this one and on observations14, 15
that bubble oxygenators cannot safely oxy
genate patients for extended periods, as can
be done with membrane oxygenators.
Bearing this in mind, this presentation
is only witness to our results of open-heart
surgery in infants using the membrane
oxygenator among several other modifica
tions in cardiopulmonary bypass technique.
It is a reliable method of oxygenating
blood in an extracorporeal circuit. Target
organs such as the lungs and kidneys,
which are commonly compromised by the
sequelae of bypass using a bubble oxy
genator, were not affected appreciably in
this group of patients. The total material
cost of bypass using this circuit is $231.00,*
compared with the total cost of using a con
ventional Bentley pediatric oxygenator of
$204.00. The other small benefit of the
membrane oxygenator is that the perfusion
ists and the nursing personnel become so
thoroughly familiar with the routine use of
such a device that the psychologic barrier to
its use in prolonged extracorporeal mem*For a 2-m2 Lane membrane, Bentley cardiotomy
reservoir, Lande reservoir, transfusion filter, prime,
tubing and suction tips.
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brane oxygenation for respiratory insuffi
ciency is not present.
We acknowledge the help given by Drs. A. V.
Krause and A. J. Stewart and perfusionists C.
Power, R. Ricketts, P. Pike, J. MacDonald, and
R. Leadon.
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indwelling _
catheterization...

Neosporin
Irrigating
Solution
(Sterile)

neomycin sulphate
polymyxin B sulphate
• helps prevent bacteriuria and Gram-negative
rod bacteremia associated with indwelling
catheters
• wide antibacterial activity against susceptible
Gram-negative and Gram-positive organisms
including most strains of Proteus and
Pseudomonas
• low index of allergenicity — low incidence of
irritation — low absorption from mucosa
• recommended in diluted solution for
continuous bladder irrigation in short-term
therapy (up to 10 days). NOT FOR INJECTION.
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PERICARDIECTOMY FOR UREMIC TAMPONADE*
J. E. MORIN, MD, FRCS[C], D. S. M ULDER, M D, MSc, FRCSfC] and
R. LONG. MD
Pericardial tamponade developed in 29 patients
with uremia. The clinical presentation varied,
some patients having no symptoms whereas
others sustained circulatory collapse. Peri
cardial friction rub, elevated central venous
pressure and a paradoxical pulse were the most
common physical findings. Serial chest radio
graphy and echocardiography were most useful
procedures in confirming this diagnosis. Two
patients were treated conservatively and died
despite repeated pericardiocentesis. The re
maining 27 patients underwent partial pericardiectomy. One patient died of cardiorespiratory
failure and a second from brain damage related
to cardiac arrest before pericardiectomy. The
other 25 patients reported immediate relief of
symptoms and no recurrence of pericarditis.
Pericardiectomy is the treatment of choice in
uremic pericardial tamponade.
Une tamponade pericardique est apparue chez
29 patients souffrant d’uremie. Le tableau Cli
nique etait variable: quelques patients ne presentait aucun symptome alors que d'autres
avaient subi un collapsus circulatoire. A I'examen physique, les observations les plus frequentes ont ete un frottement pericardique, une
pression veineuse centrale elevee et un pouls
paradoxal. Des radiographies et des echocardio
graphies seriees ont ete un moyen tres utile
de confirmer le diagnostic. Deux patients ont
recu un traitement conservateur et sont morts
en depit de pericardiocenteses repetees. Les 27
autres patients ont subi une pericardiectomie
partielle. Un patient est mort d'insuffisance
cardiorespiratoire alors qu'un deuxieme a succombe aux dommages cerebraux consecutifs a
un arret cardiaque survenu avant la pericardiec
tomie. Chez les 25 autres patients, on a signale
un soulagement immediat des symptomes et
aucune recurrence de la pericardite n'est survenue.
La pericardiectomie est le traitement de choix
dans les cas de tamponade pericardique uremique.

*From the division of cardiovascular and thoracic
surgery, McGill University, the Royal Victoria
Hospital and the Montreal General Hospital,
Montreal, Que.
Presented at the annual meeting o f the Canadian
Cardiovascular Society, Montreal, Que., Oct. 2325, 1975.
Reprint requests to: Dr. J. E. Morin, Department
of surgery, Royal Victoria Hospital, 687 Pine Ave.
W, Montreal, PQ H3A 1A1.

S in c e the introduction of hemodialysis,
survival of patients with uremia has in
creased and the occurrence of uremic peri
carditis with effusion is recognized more
frequently. The management of these pa
tients, however, is still controversial. While
in the past the appearance of pericarditis
was almost always a sign of imminent death,
most patients with pericarditis now can be
treated successfully and continue their pro
gram of renal dialysis or kidney transplanta
tion.
P a t i e n t s , C l in ic a l F e a t u r e s a n d
R e s u l t s o f I n v e s t ig a t io n

From 1968 through 1974, 29 cases of
uremic pericardial tamponade were recorded
at the Royal Victoria Hospital and the
Montreal General Hospital (Table I). Of the
29 patients, 18 were male and 11 were fe
male; their ages ranged from 15 to 70 years,
but 13 of the 29 patients were under 30
years of age. Most of the patients had been
hospitalized for reasons other than their
cardiac condition, including chronic hemo
dialysis or pretransplant evaluation.
The severity of their subjective symptoms
ranged from little acknowledgement of dif
ficulty to severe circulatory collapse; the
symptoms included fatigue, chest pain, short
ness of breath and peripheral edema. There
was little correlation between subjective
symptoms and the actual degree of peri
cardial effusion.
The physical findings are presented in
Table II and the results of diagnostic studies
are listed in Table III.
Of the diagnostic studies used to confirm
the clinical impression of tamponade the
most reliable was chest radiography, which
demonstrated in all 29 patients a recent and
progressively enlarging cardiac silhouette
suggestive of pericardial effusion. Echocar
diography also was reliable; in the 12 pa
tients in whom it was used, effusion was
demonstrated in each. The isotope scan
findings were compatible with pericardial
effusion in eight of nine patients, but the
electrocardiogram was characteristic in on-
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TABLE I.—D etails of 29 U remic P atients Concerning B lood Values, D ialysis
and P ericardiocentesis
Serum Length of dialysis
BUN, creatinine, before pericardiec Pericardiocen
Outcome
tomy, mo
tesis
mg/dl
Age, yr mg/dl
Patient no.
Died
21
Yes
5.4
33
15
* 1............................. ........
Alive
16
No
4.8
153
20
2 ............................. ........
Alive
0.1
No
11.6
68
22
3 ............................. ........
Died
Yes
19.2
0.6
153
22
4............................. ........
Alive
No
13.5
0.25
90
23
5 ............................. ........
Alive
No
36
5.2
118
23
6 ............................. ........
Alive
17
No
5.8
111
24
7 ............................. ........
Alive
11
No
8.2
160
24
8.............................. ........
Died
48
No
10.2
24
97
9............................. ........
Alive
No
2.5
6.8
128
25
10............................. ........
Alive
24
No
4.4
76
28
11............................. ........
Alive
12
Yes
14.4
60
29
12............................. ........
Alive
37
No
6.2
136
29
13............................. ........
Alive
No
6.0
24
120
35
14 ........................ ........
Alive
No
3
4.6
88
35
15............................. ........
Died
Yes
6.4
40
36
*16............................. ........
Alive
4
Yes
9.5
56
37
17............................. ........
Alive
No
48
6.7
164
38
18............................. ........
Alive
Yes
8.8
36
114
39
19............................. ........
Alive
No
12.7
156
40
20............................. ........
Alive
Yes
6.2
28
74
42
21............................. ........
Alive
No
24
5.8
106
42
22 ........................ ........
Alive
No
10.0
25
44 87.4
23............................. ........
Died
Yes
6
140
6.9
48
24............................. ........
Alive
No
28
4.9
104
52
25............................. ........
Alive
No
17
6.0
20
52
26............................. ........
Died
Yes
1
9.8
165
63
27 ........................... ........
Alive
No
11.0
141
67
28............................. ........
Died
No
5.9
3
132
70
29............................. ........
*Did not have pericardiectomy.
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TABLE I I —P hysical F indings in 29 P atients ly nine (the other 20 manifested nonspecific
with Uremic P ericardial T amponade
ST-T wave changes).
No. of
Finding
patients
Elevated central venous pressure...
25
Pericardial friction rub*....................
23
Paradoxical pulsef............................
17
Systemic hypotension (< 100
mm Hg)..........................................
12
Peripheral edema..............................
9
*In some patients, pleuropericardial.
(Associated with a decrease in arterial pressure of 10
to 46 mm Hg with inspiration.

All the patients in this series had renal
failure, blood urea nitrogen (BUN) concen
trations ranging from 20 to 165 mg/dl and
creatinine concentrations from 4.6 to 19.2
mg/dl.
R esults

of

T reatment

Pericardiocentesis was performed in 9 of
the 29 patients for relief of their symptoms,
but this was only of temporary benefit. The
effusion recurred rapidly and the symptoms
TABLE III.—R esults of D iagnostic
reappeared with increased severity.
P rocedures
Anterolateral pericardiectomy, through
left
thoracotomy, was performed in 27 pa
No. of
tients.
Two of these patients died. One pa
patients with
positive
No. of
tient
died
from massive gastrointestinal
findings
patients
Investigation
hemorrhage and aspiration that preceded
Serial chest
renal failure and pericarditis; the second
29
29
radiography...........
died from profound irreversible brain dam
12
12
Echocardiography. . .
9
29
age 11 days after cardiac arrest had devel
Electrocardiography .
8
9
Isotope scanning.......
oped on the ward following pericardiocen-
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tesis and before pericardiectomy. The im
mediate postoperative course in the other
25 patients was uneventful, though 3 died
later. One died after 6 weeks from myocar
dial infarction, another died after 18 months
from acute hemorrhagic pancreatitis, and
the third died after 3 years from subarach
noid hemorrhage.
Two patients did not undergo pericar
diectomy; in them progressive tamponade
led to cardiac arrest despite repeated peri
cardiocentesis, and resuscitation was unsuc
cessful.
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rupture these vascular adhesions and pro
duce the characteristic hemorrhagic effusion.
Progressive pericardial effusion or tam
ponade was diagnosed most often by evi
dence of elevated venous pressure, often
accompanied by a friction rub. Although a
paradoxical pulse was present in one-half of
our cases, according to Alfrey and col
leagues*’ it is not a reliable sign. Ascites and
edema were infrequently found in patients
presenting with this acute complication of
their uremia although hepatomegaly was
found in several. Ali-Regiaba and asso
ciates5 have reported that 80% of those
D iscussion
with uremic pericarditis will have fever and
With the longer survival of uremic pa 60% will have leukocytosis, while 54%
tients, uremic pericarditis is becoming recog will become hypotensive during a dialysis
nized more frequently, especially in the program.
younger patients. Bailey and colleagues1
Concerning substantiation of the diag
reported an incidence of 41% and others nosis, Collins and associates2 agreed that
have put it as high as 5 0 % .2 Although peri the regular chest radiograph gives the most
carditis seems to occur with greater fre consistently positive results, showing the en
quency within the 1st year of dialysis, it larged, globular cardiac silhouette in 100%
may occur at any time.
of cases. Constrictive pericarditis is rare in
The cause of this entity is largely un uremia7- s so that the presence of these
known. Viruses, uremic toxins and chemical symptoms with a small cardiac silhouette is
abnormalities all have been incriminated as infrequent. Echocardiography is a relatively
etiologic agents.1- 2 Compty, Cohen and new procedure and gives reliable results
Shapiro2 have postulated that pericarditis quickly and easily, and so seems ideal for
is an indication of poor control of uremia, use in these patients who, at the time of
yet pericarditis develops in 16% of those diagnosis, are often critically ill.9 Although
on dialysis programs at some time in the the electrocardiogram is almost always ab
course of the disease. Obviously, in not all normal in these patients, it rarely shows the
of these patients do effusions accompany concave ST elevation and T-wave inversion
the inflammatory process in the pericardium, characteristic of pericarditis.2 Usually the
and the prognosis for most patients with electrocardiogram shows nonspecific changes
uremic pericarditis is good if proper treat and low voltages.
ment is instituted.2
The fluid in uremic effusions is almost
The inflammatory process in the uremic always bloody2- G- 10- 11 and Merikas, Sapatient is not limited to the pericardium but martzis and Marketos12 have used pericar
seems to affect serous membranes through diocentesis as the treatment of choice for
out the body.1- 4 Thus, the characteristic tamponade. But because the fluid in the
friction rub is often not simply pericardial pericardial cavity contains large fibrin clots
but has a pleural component as well. In and is often loculated,2 each pericardial tap
many patients the chest radiograph shows removes only a small portion of the fluid.
evidence of pleural effusions before the Most agree that, even when symptomatic
pericardial effusion becomes manifest. Ali- improvement follows pericardiocentesis the
Regiaba and colleagues0 have speculated improvement is short-lived as the fluid ra
that in uremia the serous membranes under pidly reaccumulates.2- 3 Collins and col
go a subacute inflammatory process with leagues2 have advocated one attempt at peri
the formation of vascular adhesions between cardiocentesis before pericardiectomy, but
visceral and parietal pericardium. Cardiac beyond this is not justified. In our series the
pulsations engender shearing forces that may two patients who died without operation
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each had undergone several pericardiocen
teses and in all patients the fluid reaccumu
lated with progression of their symptoms.
Although all these patients have severe
renal disease, it is not possible to identify
those in whom pericarditis and tamponade
will eventually develop. The BUN and se
rum creatinine values are almost always ab
normal but there is no correlation between
the values and the development of pericar
dial effusion.3’ 4- 10
Bailey and colleagues1 have reported a
72% cure rate of uremic pericarditis with
intensive hemodialysis. However, cardiac
tamponade is a lethal complication and is
not amenable to prolonged therapy. In
Hager’s 13 view dialysis, by mobilizing the
intravascular fluid faster than the extravascular fluid and thus compromising an
already marginal venous return, may worsen
the patient’s condition rather than improve
it.
The mortality from uremic pericarditis
is said to be 12% .3 The mortality and mor
bidity of pericardiectomy is negligible and
improvement after operation is manifested
by a decreased venous pressure and im
provement of cardiac output. Because of
the initial two deaths in our series and the
rapidity with which acute, pericardial tam
ponade and death can supervene, we now
follow a specific program in treating all pa
tients with uremic pericarditis.
At the first sign of pericarditis all patients
are assessed clinically regarding pulsus paradoxicus, Kussmaul’s sign, venous pressure
and hypotension. After the initial chest ra
diographs and echocardiograms have been
obtained, dialysis is performed on at least
every 2nd day, with regional heparinization.
This form of therapy is continued as long as
there are signs of improvement or there is
no increase in heart size or echocardiographic evidence of increasing pericardial
fluid. The development of a significant
effusion either clinically or even symptoma
tically as shown by echocardiography is suf
ficient justification for immediate anterior
pericardiectomy. This approach has been
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associated with no mortality and little mor
bidity. We do not give corticosteroids,
though the study of Eliasson and Murphy14
suggests that steroid therapy may be a use
ful alternative in the high-risk patient. We
reserve pericardiocentesis for emergency
use only, and usually it is performed with
the patient in the operating room. Pericar
diectomy prevents recurrence of this com
plication.4
Uremic pericarditis, therefore, should be
treated by a specific program that includes
pericardiectomy if tamponade has been
diagnosed.
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A NEW MODEL FOR ASSESSMENT OF MYOCARDIAL FUNCTION:
I. DESCRIPTION AND PERFORMANCE NORMS*
COLIN E. BAYLISS, MD, FRCS[C],t FLORA B. CRAWFORD, RN and
BAFFOUR NSAFOAH, BSc
Use of a new isometric rabbit-heart model, a
modification of Langer's original preparation, has
permitted independent assessment of myocardial
perfusability in addition to contractility and re
laxation. In this model an isolated, paced, inter
ventricular septum contracts against a tension
transducer and is perfused from another awake
rabbit. Heparinized, diluted arterial blood is
warmed and pumped at 1 m l/g*min. Perfusion
pressure is measured by transducer. Each pre
paration serves as its own control.
This model was used in determining perform
ance norms for 68 preparations. Contractility was
measured by maximum active tension, maximum
rate of increase of tension and time to peak
tension; relaxation by resting tension, maximum
rate of relaxation and relaxation time; and per
fusability by mean perfusion pressure and mean
conductance. The status of the parabiotic rabbit
was closely monitored. These studies have shown
that the model is relatively simple, clearly de
fined and adaptable to a variety of experimental
protocols.
L'emploi d'un nouveau dispositif isometrique du
coeur de lapin, une modification de la prepara
tion originelle de Langer, a permis de mesurer
la capacite de perfusion du myocarde en plus
de la contractilite et de la relaxation. Dans ce
dispositif, un septum interventriculaire isole et
stimule se contracte contre un transducteur de
tension et est perfuse a partir d'un autre lapin
eveille. Le sang arteriel dilue et heparine est
rechauffe et pompe a raison de 1 ml/g .min.
La pression de perfusion est mesuree a I'aide
du transducteur. Chaque preparation sert de
propre temoin.
Ce dispositif a servi a determiner les normes
de performance de 68 preparations. La contrac
tilite a ete mesuree par la tension active maxi
mum, le taux maximum d'augmentation de la
tension et le temps necessaire pour atteindre

*From the department of surgery, University of
Toronto, Toronto, Ont.
Supported by a grant from the Ontario Heart
Foundation.
Presented in part at the annual meeting of the
Canadian Cardiovascular Society, Montreal, Que.,
Oct. 23-25, 1975.
fScholar of the Medical Research Council of
Canada.
Reprint requests to: Dr. C. E. Bayliss, Depart
ment of surgery, Medical Sciences Building, U ni
versity of Toronto, Toronto, ON M5S 1A8.

la tension maximum; la relaxation, par la tension
au repos, le taux maximum de relaxation et le
temps de relaxation; et la capacite de perfusion,
par la pression de perfusion moyenne et la con
ductance moyenne. L'etat du lapin en parabiose
a ete constamment surveille. Ces etudes ont
montre que le dispositif est relativement sim
ple, clairement defini et qu'il peut s’adapter a
une diversity de protocoles experimentaux.

T h e r e has, in the 1970s, been increasing
interest in the physiologic correlates of myo
cardial ischemia, interest that has been
stimulated by new possibilities for medical
and surgical treatment of coronary artery
disease. Direct measurements of the subtle
changes in myocardial contractility, relaxa
tion and perfusability have been a continu
ing challenge.1
Whole-heart models, despite physiologic
perfusion and ingenious methods of instru
mentation, provide hemodynamic data that
require complex conversion to the basic
units of force provided by isolated muscle
models. Isolated preparations, on the other
hand, depend on oxygen diffusion from a
water bath and have the disadvantage of a
potentially hypoxic central core. Isometric
models are attractive because they eliminate
the variables of changing active state and
afterload that alter performance in shorten
ing muscle fibres.1' 2
Attempts to combine the advantages of
isolated, isometric function and physiologic
perfusion in a working heart model have not
been entirely successful. Improvements3’ 4
on the classic Langendorff model5 convert
it to a working preparation but retain the
disadvantage of an anoxic washout perfu
sion using Krebs-Henseleit bicarbonate buf
fer; models using partially isolated, perfused
ventricular segments6' 7 present difficulties
in measuring perfusion and muscle force;
and a perfused papillary muscle preparation,
tried by Langer and Brady8 in 1963, be
cause of technical difficulty in cannulation,
was found less satisfactory than rabbit in
terventricular septum.9 This last model was
used in much of the classic work on ionic
flux by Langer;10 its only inadequacy is a
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relatively unsophisticated perfusion system,
consisting of an unmonitored, controlledflow, single passage of heterologous red cells
in balanced electrolyte solution.
The purpose of this communication is to
describe a new model that modifies Langer’s
original preparation by introducing moni
tored parabiotic perfusion. The possibility
of assessing myocardial perfusability is thus
added to the model’s already well-estab
lished capacity to measure directly con
tractility and relaxation.
M ethods

Septal Preparation and Mounting
A 3-kg male New Zealand white rabbit
is heparinized and then anesthetized with
an intravenous injection of sodium pentothal. The heart is excised through a median
sternotomy and placed in warm Normosol-R
(pH, 7.4) before it is dissected.
The preparation and mounting of a trianr ig h t v e n t ric le
p u lm o n a ry a rte ry
rig h t atrium

e x c is e rig h t v e n t ric le a n d a t ria
transect a b rta e x p o sin g
left c o ro n a ry artery
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gular segment of interventricular septum are
illustrated in Fig. 1. Perfusion is established
within 2 to 5 minutes of excision. Dissection
is facilitated by pinning the heart to a flat
wax surface, by using optical loupes (mag
nification power, 2.5) and by ensuring good
illumination. The perfusion cannula is made
from polyethylene-50 tubing and has a small
bulb 4 mm proximal to a finely drawn tip;
it is held in place by a 6-0 suture. The stump
of tricuspid papillary muscle marks the best
position for the apical suspending suture
and the most distal point of septal artery
perfusion. The atrioventricular node is ex
cised to remove any tendency for rapid
spontaneous rhythm. Before the base clamps
are applied the septum is suspended from
the strain gauge and weighed to determine
the tissue perfusion flow of 1 ml/g-min. The
output from a Grass SD-9 stimulator is
delivered through the base clamps or 28gauge platinum electrodes inserted in the
myocardium (Fig. 2). Perfusate drips from
the double endocardial surface of the sep
tum and keeps the tissue moist. A 24gauge Yellow Springs thermistor needle is
inserted into the tissue to monitor septal
temperature.
The mounting system is an aluminum
yoke, detachable from a vertical plastic
frame. The two base clamps are controlled
by Palmer micromanipulators so as to exert
slight lateral tension. The suspending suture
is linked to a Statham UC-4 silver cell ten
sion transducer by a detachable metal hook.
The transducer can be moved in all direc- 5 -0 suspending suture

- trim to remove all
>n-perfused tissue
tric u sp id p a p illa r y m uscle

excise left ventricle
excise aortic root
and A-V node

d e ro o f le ft c o ro n a ry artery

se ptal a rte ry

suspend from strain gauge at
stable resting
tension of 5-10 g

pacer stimulus
con be delivered

small toothed clamps under
slight lateral tension

P E “ 5 0 septal
a rte ry c a n n u la

course of septal artery

p e rfu sio n

Fig. la

Fig. lb
Fig. 1.—(a) Stages in septal preparation, (b)
Septal preparation and mounting.
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Fig. 2.—Model for assessment of myocardial function. Arterial
circuit stippled.

tions by means of a Narishige micromanipu
lator permanently mounted on the plastic
frame. For applications requiring a signi
ficant period of organ storage, the hook is
clamped to the yoke and the yoke and sep
tum are removed from the frame to the
storage environment. The unit is reassem
bled for direct measurement of contracture
(i.e., level of resting tension) and reperfu
sion following storage.
The Parabiotic Rabbit
A 3-kg male New Zealand white rabbit
is lightly restrained in a metal rabbit-holder.
Warmth, from an electric heating pad, re
laxes the animal and promotes vasodilation.
Two 22-gauge plastic cannulas are inserted
into an ear artery and opposite ear vein un
der local anesthesia. A small transverse cutdown aids positive identification of the
artery in the median neurovascular bundle.
Through the venous cannula the animal
then receives a slow infusion of 2000 units
of heparin, 10 ml of Normosol-R (pH, 7.4)
and 10 ml of “flow-promoting cocktail”
(consisting of 150 ml Normosol-R, 10 g
dextran 40, and 1.5 g Pluronic F-68, filtered
to exclude bacteria and stored at 4°C).
Under restraint, calm but awake rabbits
manifest a tendency to spontaneous and
lethal hyperventilation. For this reason, a
low flow of carbon dioxide (C 0 2) (500
ml/min) is directed to the area of the ani
mal’s nose and adjusted to maintain normal
arterial C 0 2 tension (Pco2). Fluid deficits
are corrected with Normosol-R, and meta
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bolic acidosis is reversed with 7.5% sodium
bicarbonate solution. With careful manage
ment the parabiotic rabbit remains stable
for up to 3 hours of recirculation.
The Perfusion Circuit
Fig. 2 illustrates the central components
of the model. Tubing consists of Silastic
rubber segments joined by 14-gauge needle
adapters at connections. The system is
primed with 30 ml of Normosol-R and 1000
units of heparin. Diluted blood is slowly
recirculated for 10 minutes before septal
mounting. Flow is controlled by a calibrated
Holter pump.
The rabbit’s arterial pressure is monitored
just distal to the ear cannula by a Micron
MP-15 transducer. A 20-ml collapsible rub
ber reservoir is inserted in parallel with the
arterial line between the rabbit and pump
head. If arterial spasm interrupts smooth
perfusion, back pressure of the distended
reservoir tends to break the spasm. If ob
struction persists, the reservoir provides
enough fluid for a further 10 to 20 minutes
of perfusion. When closed, the arteriovenous
shunt at the level of the ear cannulas directs
circulation through the parabiotic rabbit;
when open the shunt excludes the animal
from the circuit and perfusion can be main
tained despite arterial spasm or instability
of the rabbit’s condition.
The arterial manifold is the core of the
perfusion monitoring system. Arterial P co2
is measured continually by a General Elec
tric electrode with its tip positioned adjacent
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to a Yellow Springs thermistor probe in the
distal portion of the manifold. The Pcoa
electrode is calibrated periodically and acidbase balance determined in arterial blood
by a conventional Radiometer bench-top
electrode system. The perfusate is heated to
40°C by a circumferential in-line heater
controlled by a variable power supply. A
Micron MP-15 pressure transducer measures
mean and phasic pressure in the slightly
pulsatile system. A resistance artifact of 20
to 25 mm Hg is determined for each septal
cannula and applied as a correction factor.
The side arm in the distal manifold is used
to inject drugs or to introduce a different
perfusate, if desired. Optimal position for
the septal cannula is maintained by clamp
ing the entire manifold in a Narishige micro
manipulator. Perfusate dripping from the
surface of the septum is collected in a fun
nel-reservoir and returned to the rabbit via
the venous line.

Assessment of Myocardial Function
The mounted septum is paced at 60 beats
per minute. The stimulus blip is recorded
on the first channel of a four-channel Brush
recorder and simultaneously displayed on a
storage oscilloscope in the variable persist
ence mode. The stimulus voltage is adjusted
to remain just above capture (5 to 10 V)
and the duration of the square wave is ad
justed to 2 ms. A photographic record of
the stimulus variables is made with a Pola
roid oscilloscope camera.
Tension recordings are made by the
weight-calibrated tension transducer and
displayed on the second channel of the
Brush recorder. Resting tension is adjusted
to a level between 5 and 10 g and allowed
to stabilize for 30 minutes. If the septum
has been damaged during preparation, loss
of contractility leads to progressive diminu
tion of maximum active tension and con
tracture results in progressive increase in
the resting tension. Septa are discarded if
either eventuality is noted during the 30minute stabilization period. Measurements
taken directly from the tension tracing are
maximum active tension (total tension minus
resting tension), resting tension, time to peak
tension and relaxation time.
The differential of tension is displayed on
the third channel of the Brush recorder. Ex
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cellent vibration-free mounting of the ap
paratus is essential to obtain clear differen
tial tracings. A mechanical function gen
erator is used to calibrate the differentiator;
this is thought to have the advantage of test
ing the transducer circuit. Measurements
taken directly from the differential tracing
are maximum rate of increase in tension and
maximum rate of relaxation.
The manifold perfusion pressure at con
stant flow is displayed on the fourth channel
of the Brush recorder. The pressure trans
ducer is calibrated by mercury manometer
and zero levels are checked periodically
throughout the perfusion. The pressure is
slightly pulsatile (pulse pressure, 10 to 15
mm Hg) owing to the action of the Holter
pump, so that mean pressure is used to cal
culate conductance (flow per unit pressure)
in assessing perfusability. If control pres
sures exceed 150 mm Hg (indicating ex
cessive resistance) the septum is rejected.
During use of the model for testing
an experimental hypothesis, each septum
would act as its own control, with baseline
recordings taken after 30 minutes of stable
function. These measurements would then
be compared with similar measurements
taken after the experimental intervention.
R esults

Septal Function
A typical tracing from a stable septum
after 30 minutes of perfusion is shown in
Fig. 3. There is no discernible effect of
contraction on the pressure tracing. Despite
the slight compliance of the system, the
model is essentially isometric.
A summary of the performance norms
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Fig. 3.—Typical tracing from stable septum
after 30 minutes of perfusion.
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TABLE I.—P erformance N orms
fused Septa

for

68 P er 

Norm (mean ±
SD) after 30 min
of stable
function

Performance*
Contractility
14.3 ± 7.2
T m a x , g ....................................
100 ± 67
dF/dtmax, g/S.........................
261 ± 82
TPT, m s.................................
Relaxation
6.7 + 1.7
Tr,.«. g ................................
70 ± 51
—dF/dtmax, g / s ..............
549 ± 167
RT, m s...............................
Perfusability
97 ± 24
P, mm H g..........................
11.1 ± 3.3
C, td/g- min- mm H g. . . .
*Abbreviations: Tmsx, maximum active tension;
dF /dtm.„, maximum rate of rise of tension; TPT,
time to peak tension; Tr(,st, resting tension; —d F /
dtmnl, maximum rate of relaxation^ RT, relaxation
time; P, mean perfusion pressure; C, mean conduct
ance (flow per unit mean pressure).

for 68 preparations after 30 minutes of
stable function is presented in Table I.
The Parabiotic Rabbit
Details concerning the status of the para
biotic rabbit in 68 preparations are set forth
in Table II. These values were obtained at
the beginning of perfusion and maintained
for 30 minutes. They emphasize that, by
human standards, normal acid-base status
for a rabbit is a mild state of respiratory and
metabolic alkalosis. It is only possible to
maintain a constant Pco2 in the presence
of the inevitable spontaneous hyperventila
tion by administering small quantities of
C 0 2 in the inspired air. The proportion
of CO-2 in the mixture must be varied in
response to continuous arterial Pco2 moni
toring.
The hematocrit dilution attributable to
use of priming fluid and “flow-promoting
cocktail” is 15%. Hemodilution of this or
der has no effect on the adequacy and dis
tribution of coronary blood flow.11
TABLE II.—Status

of

68 P arabiotic R abbits

Value
Variable*
(mean ± SD)
pH ...............................................
7.45 ± 0.05
PCO2 , mm H g............................
37 ± 4
Base excess, m m ol/1................
+ 2.3 ± 2.7
PO2 , mm H g..............................
89 A 6
Hematocrit, %
Normal...............................
37.2 ± 2.9
Diluted...............................
31.6 ± 2.8
Arterial pressure (mean),
mm H g...................................
87 ± 10
*Blood-gas values are for arterial blood.
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D iscussion

In the intact animal or human, the heart
is inaccessible for direct measurement of
muscle function. Direct access requires that
a surgical procedure be combined with
mechanical intervention that frequently al
ters function. At best, the data are either in
direct or approximate. Although whole
hearts can be artificially perfused, dither the
perfusate or the perfusion system is rela
tively unphysiologic and may be difficult to
control or quantitate. Isolated papillary
muscle preparations are unperfused, and,
although they permit one to measure rela
tively pure functional variables, they may
have an anoxic central core that splints con
traction or impedes tension development.
Isometric function, though desirable, is dif
ficult to achieve in a physiologic setting
where independent variables can be con
trolled or measured. There is still no simple
and precise method for quantitating and dif
ferentiating between contracture and edema
without destroying the tissue by the analysis.
Langer’s perfused-septum model approaches
the ideal but lacks a sophisticated perfusion
system. Because the simultaneous assessment
of contractility, relaxation and perfusability
might be useful in solving problems of car
diology and cardiac surgery, it seems worth
while to adapt Langer’s model to incorporate
this capability.
The reasons for choosing the rabbit as an
experimental animal are important. This
species is available in unlimited quantities at
reasonable prices. Physiologically, though in
a delicate state of balance, basic data are
well documented and resemble those of the
human in many respects. The size of its
heart is ideal for instrumentation. Particu
larly fortuitous is the fact that the ear vessels
are large in relation to animal size, making
vascular access possible without the need
for general anesthesia.
The model can be used to simulate vari
ous conditions of cardiopulmonary bypass.
This is achieved by permutations and com
binations of temperature, perfusate composi
tion, ischemia, pacemaking and resting ten
sion. For example, a vented heart with the
aorta clamped at room temperature would
be simulated by lowering the resting tension
to zero, stopping perfusion and turning off
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the stimulator. Similarly, an unvented,
fibril lating heart with coronary artery per
fusion at 30°C would be simulated by in
creasing the resting tension to 20 g, applying
a fibrillating current from the stimulator and
perfusing with unheated blood at a pressure
of 80 mm Hg.
Metabolic studies can be carried out on
the perfusate entering and leaving the sep
tum. This capability is well illustrated by
Langer’s studies of cation kinetics.10 Meta
bolic and morphologic studies can be car
ried out on the tissue itself, if destruction
is acceptable in an experimental design. The
method of perfusion, which incorporates an
option to exclude the parabiotic animal from
the circuit, permits the testing of drugs or
perfusates on the isolated heart or on the
whole animal in addition to the heart.
There are a number of deficiencies in the
model that do not detract from its usefulness.
The triangulated septum probably has a
centripetal contraction pattern, with all
forces vectored upward to the tension trans
ducer except those at right angles to the
suspending suture. A low, flat triangle dis
sipates a good deal of force against the base
clamps; a high, peaked triangle vectors most
of its force upwards. This is a systematic
variable that is compensated for by having
each preparation, regardless of geometric
factors, act as its own control.
The process of isolating any muscle pre
paration implies an ischemic interval. The
interval varies from 2 to 5 minutes in this
model and results in septa that deteriorate
with reperfusion if damage is appreciable.
Any septum that does not remain stable in
all respects for 30 minutes of control perfu
sion must be rejected from further study.
Whether the double endocardial surface
of the septum is a benefit or a liability is
not known. It probably results in fairly uni
form perfusion but may not typify free
ventricular myocardium. Its main advantage
is that thebesian venous leakage keeps all
surfaces wet, a situation that would not
occur if one of the surfaces was epicardial.
The deleterious effects of a blood-gas inter
face12 appear to be largely nullified by the
parabiotic animal in the circuit and this may
be the major advantage of the system.
The model is, of course, purely an acute
denervated preparation. It cannot provide
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answers to questions involving the long-term
effects of metabolic injury but it may identi
fy minor short-term abnormalities that form
the basis for later problems. To test any
hypothesis involving innervated myocar
dium, the experimental stress would have to
be applied to the intact donor prior to septal
harvest or simulated in the control septum.
This communication describes and docu
ments performance norms of a new model
for assessing myocardial function. Testing
and further speculation on its applicability
will be the subject of future reports.
We gratefully acknowledge the advice and en
couragement provided by Drs. G. A. Langer and
J. V. Maloney, Jr., University of California Los
Angeles, and acknowledge, with thanks, the con
tributions of Abbott Laboratories, The Upjohn
Company and Deknatel Inc.
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GLIMPSES OF SURGICAL HISTORY:
H FOR HEMOSTASIS
D. A. E. SHEPHARD

The stanching of blood from wounds has
always been of fundamental importance to
man’s health, and it is not surprising that
the history of HEMOSTASIS is lost in the
mists of time. Blood, too, has always had
magical and religious meaning, and, in the
history of hemostasis, factors that are clear
ly not surgical are not easy to separate from
those that are. But one’s glimpse has sharper
focus if one notes that hemostasis has but six
main bases: compression, cautery, the tourniquet, the ligature, and blood fractions and
absorbable hemostatics.
One group of hemostatic remedies did not
presuppose any knowledge of anatomy and
physiology. Digital pressure and local rem
edies of plant origin had primitive roots, and
cautery is nearly as old as man’s use of fire.
Chemical agents, too, have a long history:
the Egyptians, for example, used lead sul
fate, antimony and copper sulfate, the “hemo
static button”. Their remedies were effective
but, with a mainly surface action, their ef
fect was transient.
Specific, permanent remedies came later.
One reason was that in certain eras— the
post-Galenic, the Saracen, and the preRenascent particularly—dissemination of
knowledge was slow or impeded. Then a
fundamental invention, printing, made basic
knowledge available to all permanently; the
best of the knowledge of the great classical
writers spread, no longer obscured by the
formalism and mysticism that had stifled
surgical science. The great discovery of the
circulation was publicized, without delay,
as were the second group of hemostatic
remedies.
One such remedy was the ligature, and
the catgut ligature especially shows how
much surgery owes to human endeavour in
\o th e r fields. Catgut long had had many
\nonmedical uses and thus was well known
w>hen Lister carbolized it and used it in
preference to silk for suturing. In so doing
a great surgeon applied ancient knowledge
in a modern manner and perfected the tech
nical management of a surgical problem that
had taken thousands of years to overcome.
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Coronary artery bypass grafting is a new
procedure which has not been completely
evaluated. The long-term results of grafting
procedures utilizing the autogenous veins or
the internal mammary artery for bypassing
the occluded portions of the proximal coro
nary artery are continually being reevalu
ated. There is agreement that the risk of the
operative procedure is related to the ex
tensiveness of the arterial changes and the
impairment of ventricular function which
may be due to factors other than ischemia.
Evaluation of ventricular function is a con
sideration in the choice of patients. Those
with severe dysfunction are found to have
poor tolerance for the operation; higher
mortality is incurred in this group of patients.
The indications for coronary artery re
vascularization are slightly enlarged in the
case of patients on whom the open-heart
procedure is done for other lesions, such as
valvular heart disease or ventricular aneur
ysm, as in answer (3). Certain lesions, be
cause of their location, such as the main left
coronary artery, are more life-threatening
than similar degrees of stenosis in more
peripheral vessels. The indication for opera
tion in this group seems more urgent, as
represented in answer (2). The evaluation
of angina pectoris remains somewhat less
well defined since patients with progressive
angina with impending coronary occlusion
would be a logical group for whom the op
eration should be considered. Selection with
in this group requires somewhat greater
skill and more sophisticated methods for
evaluating the condition of these patients.
Those with disabling angina are given some
priority if arteriographic studies show that
their situation is favorable for grafting.
A
Reference
404/1. Shirley EK: Selection of the sur
gical candidate. Surg Clin North A m 51:
1023-1033, 1971

27 boked pololoes^nsandQo,
orone Allbee with0550.
PostoDerative care, acute infection, long-term illness or convalescence-whenever a
nutritional supplement is indicated, remember Allbee with C-550. One capsule daily
gives your patient as much Vitamin C as 27 baked potatoes, skins and aH.andfuU
therapeutic amounts of the B-complex vitamins, including as much niacin as 2pounds
of sirloin steak. Allbee with C-550 is available at pharmacies on your prescription or
recommendation in bottles of 30,100, and 500.
For complete prescribing inform ation, consult product literature o r the Compendium.

A. H. RobinsCo. of Canada, Ltd., Montreal, Quebec.

NS

128

TH E CANADIAN JO U RN A L OF SURGERY

Vol. 19

IN TRA-AORTIC BALLOON PUMP ASSIST: ADJUNCT TO SURGERY
FOR LEFT VENTRICULAR DYSFUNCTION*
BERNARD S. GOLDMAN, MD, BSc(Med), FRCS[C], PAUL WALKER MD
JOHN GUNSTENSEN, MB, ChB, FRCS(Edin) FRCSfC], HUGH E SCULLY MD
MSc(Med), FRCS[C] and ALLAN G. ADELMAN, MD, FRCT[C]
’
Intra-aortic balloon pump assist (IABPA) was
used intraoperatively and postoperatively in
34 patients with severe left ventricular dysfunc
tion: the mean ejection fraction was 0.29 and
all patients had angiographic grade IV left
ventricular contractility. There were three groups
of patients: 11 patients with acute coronary
artery insufficiency— 10 of whom survived vein
bypass surgery (group 1); 16 patients with
crescendo-type unstable angina— of whom 15
survived surgery (group 2); 7 patients with sin
gle (6) or multi valvular (1) replacement (com
bined with vein bypass in 3)— of whom 5 sur
vived (group 3). Overall survival was 8 8 % . The
mean duration of 1:1 IABPA was 40 hours. Ino
tropic support was not required, hem olysis was
insignificant and hemostasis remained secure.
Two patients required tracheostomy and one re
quired dialysis. One patient had a peripheral
embolus in the leg used for IABPA.
IABPA improves subendocardial perfusion dur
ing induction of anesthesia, during cardiopul
monary bypass and into the postoperative pe
riod; left ventricular work is decreased with a
concomitant increase in coronary artery and vein
graft blood flow. Use of IABPA may also improve
survival and lessen morbidity in patients with
left ventricular dysfunction due to the benefi
cial effects on myocardial performance and is
thus a valuable adjunct to cardiac surgery in
high-risk patients.
L assistance d'une pompe a ballonnets intraaortique (PBIA) a ete mise a profit durant
la periode pre- et post-operatoire chez 34 pa
tients presentant une insuffisance ventriculaire
gauche grave: la fraction d ’ejection moyenne
etait de 0.29 et tous les patients presentaient
a I angiographie une contractilite ventriculaire
gauche de grade IV. On comptait trois groupes
de patients: 11 patients avec insuffisance coronarienne aigue dont 10 survecurent a une ope-

*From the departments of surgery and medicine,
University of Toronto, and the division of cardio
vascular surgery, Toronto General Hospital, To
ronto, Ont.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Montreal, Oue., Oct 2325, 1975.
Reprint requests to: Dr. B. S. Goldman, Division
of cardiovascular surgery, Toronto General Hos
pital, 101 College St., Toronto, ON M5G 1L7

ration de pontage veineux (groupe 1); 16 pa
tients ayant une angine instable devolution
rapide parmi lesquels 15 survecurent a la chirurgie (groupe 2); 7 patients ayant subi des
valvuloplasties simples (6) ou multiples (1)
(associees a un pontage veineux dans 3 cas),
parmi lesquels 5 survecurent (groupe 3). Le
taux de survie a ete de 88% . La duree moyenne
de (’assistance 1:1 de la PBIA a ete de 40
heures. Aucune therapeutique inotrope d’appoint n'a ete necessaire. L’hemolyse a ete peu
importante et I'hemostase est demeuree ade
quate. Deux patients eurent besoin d'une tracheostomie et un eut besoin de dialyse. Un
patient a eut une embolie peripherique localisee dans la jambe utilisee pour la PBIA.
L assistance de la PBIA ameliore la perfusion
sous-endocardiaque durant I’induction de I’anesthesie, pendant la derivation cardiopulmonaire
et pendant la periode post-operatoire. Le travail
ventriculaire gauche est diminue alors que le
debit sanguin est augmente dans les arteres
coronaires et le pontage veineux. L'emploi de la
PBIA peut aussi ameliorer la survie et diminuer la morbidity chez les patients ayant une
insuffisance ventriculaire gauche, grace a ses
effets favorables sur la fonction du myocarde;
cette technique constitue de la sorte un traitement d'appoint valable a la chirurgie cardiaque
chez les patients presentant un risque eleve.

A bbreviations
AVR
Cl
IABPA
LVA
LV ED P
LV EF
M VR
RCA
SVG
TEA
TVR

A ortic valve replacem ent
C ardiac index
In tra-ao rtic balloon pum p
assist
Left ventricular aneurysm
L eft ventricular end-diastolic
pressure
L eft
ventricular
ejection
fraction
M itral valve replacem ent
Right coronary artery
Saphenous vein graft
T hrom boendarterectom y
Tricuspid valve replacem ent

L e f t v e n tric u la r d y sfu n ctio n co m p licatin g
ischem ic o r v alv u lar h e a rt d isease, o r b o th ,
m ay in crease surgical risk an d m o rb id ity , i-*
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TABLE I.— D etails of P atients
Group
1
(n = 16)

2
(:n = 11)

3
(n = 7)

53
41 — 63

53
42 — 64

55
52 — 57

0.29
0.08 — 0.40

0.30
0.13 — 0.40

0.24
0.10 — 0.40

19.4 — 24.7
2.4
IV
12.8

18.0 — 27.0
2.6
IV
14.0

Variable
Age, yr
Average..................................................
Range......................................................
LVEF
Average..................................................
Range......................................................
Mean LVEDP (rest to postangiography,
mm H g)..................................................
C l./ min in2 ..................................................
Left ventricular angiographic grade..........
Coronary artery score..................................

22.6

— 35.0
1.9
IV
7.0*

*Score obtained in only 4 patients.

and even may be a contraindication to oper
ation because of the high risk and uncertain
functional improvement. Recent reports,
however, have demonstrated decreasing op
erative mortality and increased longevity.4' 9
We believe that patients with angina and
poor left ventricular function should not be
denied operation if there is potential for
adequate direct repair. This paper describes
our experience with surgery and intra-aortic
balloon pump assist (IABPA) in 34 patients
with significant left ventricular dysfunction.
C linical M aterial

During a 22-month period (Oct. 1, 1973
to Aug. 1, 1975) 34 patients with left ven
tricular dysfunction underwent operation
with IABPA for ischemic or valvular heart
disease or both. (During the same period,
945 open-heart operations were performed
and 125 patients received IABPA.)
The 34 patients made up three groups.
In group 1, 3 of the 16 patients with typical
crescendo angina had significant main-stem
left coronary artery stenosis. One patient
had symptoms of congestive failure as well
as ischemic pain. In group 2, 2 of the 11

patients with acute coronary artery insuffi
ciency had main-stem left coronary artery
stenosis; despite adequate medical manage
ment with analgesics, nitrites and propra
nolol, these patients had severe, recurrent,
prolonged pain at rest, often accompanied
by electrocardiographic changes of acute
myocardial ischemia. In group 3, four of the
seven patients with valvular heart disease
(six, aortic; one, multivalvular) also had
ischemic heart disease. One patient, with
end-stage aortic stenosis, was operated upon
in extremis.
All patients had a left ventricular ejection
fraction (LVEF) of 0.4 or less (calculated
from a single-plane right anterior oblique
ventriculogram) grade IV impairment of left
ventricular contractility, and elevated left
ventricular end-diastolic pressures (LVEDP)
(Table I).
Surgical P rocedures

The surgical procedures, duration of 1:1
assist and results in terms of operative
survival are summarized in Table II.
The AVCO intra-aortic balloon catheter
was inserted via a common femoral artery

TABLE II.—Operative P rocedures, D uration

of

IABPA

and

Survival

Group
1
(n = 16)

2
(« = 11)

3
(n = 7)

No. of SVGs/patient................................
Other operations performed....................

1.9
Repair of LVA x 3,
RCA TEA x 2

2.2
Repair of
LVA x 2

1.5*
AVR x 6,
AVT, MVR, TVR x 1

Duration 1:1 IABPA (hr)
Average..............................................
Range..................................................
Operative survival....................................

46.7
18 — 96
15

40.9
6 — 92
10

25.0f
15 — 48
5

*3 patients.
)5 patients.
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under local anesthesia before induction of
general anesthesia or endotracheal intuba
tion. In group 2 (acute coronary artery in
sufficiency) IABPA was instituted before or
during hemodynamic evaluation in five pa
tients; in one extremely agitated patient we
unwisely elected to proceed with induction
of anesthesia before instituting IABPA. Af
ter intubation this patient suffered an acute
myocardial infarction with cardiac arrest
and could not be resuscitated despite
IABPA and coronary artery bypass.
IABPA was maintained during cardiopul
monary bypass, the console being triggered
by a signal from an external pacemaker,10 13
and into the postoperative period. After
cessation of 1:1 assist, weaning was usually
rapid and balloon removal was accomplished
whenever operation schedules permitted.
R esults

Group 1
Despite triple saphenous vein bypass
grafts and successful weaning from balloon
support within 96 hours, one patient, who
had predominant symptoms of congestive
heart failure, died in hospital 4 weeks after
operation of respiratory and renal failure
aggravated by sternal dehiscence. This pa
tient would not now be considered a can
didate for direct revascularization.
Group 2
In the one patient in group 2 who died,
rapid institution of IABPA after induction
of general anesthesia resulted in cardiac
arrest. The balloon catheter should have
been inserted before general anesthesia to
obtain an optimal balance between oxygen
supply and demand in this seriously ill pa
tient.
Group 3
In this group two patients died: in one,
a paravalvular aortic prosthetic leak resulted
in massive left ventricular distension due to
balloon counterpulsation during cardiopul
monary bypass, which was unrecognized
during construction of the proximal bypassgraft anastomoses; the patient could not be
weaned from cardiopulmonary bypass. The
other patient, who had been in extremis
(cardiac index [Cl], 0.7 Z/min-m2; LVEF,
0.01), could not be weaned from cardio
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pulmonary bypass after aortic valve replace
ment. His condition would not now be con
sidered operable.
One patient sustained a popliteal embol
ism just before discharge, presumably from
the site of balloon insertion; despite embolectomy he has mild claudication. No in
stances of arterial perforation, aortic dissec
tion or sepsis at the Dacron sleeve were
noted in the series.
Morbidity was minimal: two patients re
quired tracheostomy and one, dialysis (one
of these patients died). Inotropic agents
were not used. Occasionally, peripheral re
sistance was augmented by vasopressor to
improve proximal aortic root counterpulsa
tion and, similarly, a peripheral vasodilator
was occasionally used to decrease a hyper
tensive balloon pulse pressure. No unusual
rhythm disturbances or hemostatic problems
were related to either counterpulsation or
the use of low-molecular-weight dextran in
these patients.
D iscussion

The assessment of left ventricular func
tion is essential for the prognosis of patients
with ischemic or valvular heart disease, or
both. The mortality over 3 to 5 years for
the patient with triple-vessel occlusive dis
ease and a markedly depressed ejection
fraction from severe diffuse impairment of
left ventricular function ranges from 71 to
88% .14’ 15 Thus, if surgery for acquired
heart disease is restricted to those with good
left ventricular function, those most in need
of definitive therapy are excluded.
Clinically, left ventricular function is as
sessed by the Cl, LVEDP, LVEF (calcu
lated either from angiographic or echocardiographic findings) and the impression of
contractility afforded by the left ventriculo
gram. Subjective review of the ventriculo
gram and the LVEF are probably the most
accurate of these parameters since others
may vary with the physiologic state of after
load, preload, heart rate and wall com
pliance. All patients in this series had grade
IV impairment of left ventricular con
tractility and an LVEF of less than 0.4.16
Patients with impaired left ventricular
function face a high operative risk, which
has varied from 5 to 55%. The operative
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mortality and hospital morbidity are in in
verse relation to the calculated LVEF.17"19
When diffuse left ventricular hypokinesia is
present without angina, operation is con
traindicated, but the presence of angina or
anginal-equivalent congestive episodes, or
congestion associated with mechanical le
sions that can be repaired, such as mitral
valve dysfunction or localized aneurysm, all
suggest a possible benefit from operation
despite a poor LVEF.
Recent reports have indicated that im
proved surgical techniques result in accept
able operative mortality rates.7’ 2°, 21 If
revascularization or other reparative proce
dure can be performed without injury to an
already compromised myocardium, then the
5-year prognosis may be better than the na
tural history alone. Indeed, Isom7' 8 has
demonstrated 83% survival at 2 years. Al
though there is little evidence suggesting that
enhanced longevity is associated with im
provement in total left ventricular function,
local improvement of segmental contractility
has been demonstrated.22 There has been
renewed interest in intraoperative myocar
dial preservation and, in particular, in the
maintenance of subendocardial flow.16 Ob
viously preservation of existing left ventri
cular function in the severely impaired heart
is essential in order to decrease operative
risk and improve later survival. Operative
mortality has been reduced in patients with
poor left ventricular function by avoiding
severe hemodilution and air embolism of
the coronary artery graft, by using systemic
and topical hypothermia, by limiting or
avoiding ischemic periods, by maintaining
a high mean intra-aortic perfusion pressure
and adequate left ventricular decompression
and by periodic defibrillation.
Intra-aortic balloon pump counterpulsa
tion has been proven effective in the man
agement of patients with acute myocardial
ischemia.20’ 21 It re-established an optimal
oxygen supply/demand balance with physio
logic effects of particular benefit to those
patients with left ventricular dysfunction;
reduction of ventricular afterload may re
duce LVEDP and enhance subendocardial
perfusion, while diastolic counterpulsation
increases coronary artery perfusion pressure
and vein bypass graft flow, and may cause
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redistribution of coronary artery blood flow
in favour of ischemic areas by opening
dormant collaterals with maximal vasodila
tation. 12
IABPA temporarily corrects hemodyna
mic and electrocardiographic instability in
patients with acute myocardial ischemia,23
facilitating diagnostic catheterization, induc
tion of general anesthesia and cannulation
for bypass. Pulsatile extracorporeal perfusion
is achieved during cardiopulmonary bypass
by balloon inflation from a pacemaker sig
nal.13 Early postoperative LVEFs improve
after pulsatile cardiopulmonary bypass com
pared with mean perfusion, with a signifi
cantly decreased incidence of perioperative
infarction.11 Postoperative balloon support
has been free of arrhythmias or low-output
states, thus obviating the need for inotropic
agents.
Support with the intra-aortic balloon
pump is a valuable adjunct to other meas
ures for intraoperative myocardial protec
tion; the preservation of myocardial tissue
of borderline viability in the presence of
irreversibly scarred muscle may improve
operative risk, hospital morbidity, long-term
survival and perhaps, net left ventricular
flmction.
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G aram ycin
Injectable IM /IV
(gentamicin sulphate U.S.P.)

GARAMYCIN Injectable (40 m g (base)/m l)
GARAMYCIN Pediatric Injectable (10 mg (base)/m l)
INDICATIONS:
GARAMYCIN is indicated in the treatment ot serious infections caused by proven susceptible
organisms In suspected or docum ented gram-negative septicemia, particularly when shock or
hypotension are present, GARAMYCIN should be considered for initial antimicrobial therapy
In staphylococcal infections, GARAMYCIN should be considered when conventional antimi
crobial therapy is inappropriate o r when susceptibility testing and clinical judgment
indicate its use
ADM INISTRATIO N AND DOSAGE
IN TR AM USC ULAR /IN TR AVEN O U Sn ADM INISTRATION
A U rina ry Tract Inlections
The usual dosage in lower urinary tract infections is 0.8 - 1 . 2 m g /k g /d a y in two o r three equally
divided doses for seven to ten days For increased antibacterial activity it may be advantageous
to alkalinize the unne Infections of the upper urinary tract, such as pyelonephritis, should be
treated according to one of th e schedules fo r systemic infections
B System ic In fe c tio n s -N o rm a l R enal F unction
The treatment of systemic infections in patients with normal renal function requires a dosage of
3 m g /kg /d a y in three equally divided doses. A course of seven to ten days of treatment will
usually clear an infection due to a susceptible organism In patients with life-threatening
infections, dosages up to 5 m g /k g /d a y should be administered in three or four equally
divided doses This dosage should be reduced to 3 m g /k g /d a y as soon as clinically indicated
C. P atients w ith Im paired R enal F unction
In patients with diminished renal function or those undergoing intermittant hemodialysis, the
dosage has to be adjusted depending on the degree of renal impairment
For detailed information consult th e product monograph or the Schering Representative
niN TR AVEN O U S AD M IN IS TRA TION
The usual effective dosage of GARAMYCIN Injectable administered intravenously is
3 m g /k g /d a y in three equally divided doses.
For intravenous administration, a single dose (1 m g/kg ) of GARAMYCIN Injectable is diluted
in 100-200 ml of sterile normal saline o r 5% dextrose The solution is infused over a penod of
one to tw o hours and repeated two to three times a day The usual duration of treatment is
seven to ten days
PRECAUTIONS
O to to xicity
Gentamicin, like other aminoglycosides, has produced ototoxicity in experimental animals and
man. It is manifested by damage to vestibular function and may be delayed in onset. Damage
has occurred in patients who were uremic, had renal dysfunction, had prio r therapy with
ototoxic drugs or received higher doses o r longer therapy than those recommended. The
concomitant use of ethacrynic acid and furosemide should be avoided The physician should
strongly consider discontinuing the drug if the patient complains of tinnitus, dizziness or loss
of hearing. Serum GARAMYCIN levels in excess of 12 p g /m l should be avoided
N ephrotoxicity:
Nephrotoxicity manifested by an elevated BUN or serum creatinine level or a decrease in the
creatinine clearance has been reported with GARAMYCIN. In most cases these changes have
N eurom uscular B locking A ction
Neuromuscular blockage and respiratory paralysis have been reported in animals. The possi
bility of this occurring in man should be kept in mind particularly in those patients receiving
neuromuscular blocking agents
ADVERSE REACTIONS
Am ong other adverse reactions reported infrequently and possibly related to GARAMYCIN are
elevated SGOT, increased serum bilirubin, granulocytopenia and urticaria. Reactions reported
rarely and possibly related to GARAMYCIN include drug fever, hypotension, hypertension,
itching, hepatomegaly and splenomegaly.
OVERDOSAGE
Peritoneal o r hemodialysis will aid in the removal o t GARAMYCIN from the blood.
SUPPLIED
Each ml of aqueous parenteral solution at pH 4 5 contains. 40 mg or 10 m g (pediatric) of
gentamicin base Preservatives, methylparaben U.S.P.. propylparaben U S .P, sodium bisulfite
U.S P , disodium edetate U S.P Available in 2 ml multiple-dose vials and 1 5 ml Unidose*
ampoules containing 60 mg gentamicin base/i 5 ml Solutions are heat stable and do not
require refrigeration
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LOCALIZATION OF
UPPER GASTROINTESTINAL
TRACT HEMORRHAGE
In patients known to have esophageal
varices it can be difficult to determine the
site of bleeding within the gastrointestinal
tract. To distinguish variceal hemorrhage
from hemorrhage elsewhere in the upper
gastrointestinal tract in such patients, Rosen
berg and Harken (Surg Gynecol Obstet 142:
241, 1976) have used a test based on the
differential affinity for oxygen of blood shed
into the gastrointestinal tract and of saline
instilled into the stomach.
The oxygen tension of saline solution used
for instillation is 150 mm Hg; its oxygen
content is 0.4 vol%. Hemoglobin in blood
lost into the stomach is desaturated, and any
desaturated hemoglobin in venous blood in
the vicinity of oxygenated saline will cause
oxygen to leave this saline solution. Variceal
bleeding and bleeding from gastritis or ulcer
can therefore be distinguished by deter
mining the oxygen tension of blood-stained
saline that was irrigated the stomach.
Rosenberg and Harken first administered
oxygen (8 l/min) by face mask for 3 to 5
minutes before making any tests. The sto
mach was lavaged free of clots through a
nasogastric tube. A saline solution (100 ml)
was instilled into the stomach, and samples
of arterial and venous blood taken for
oxygen tension and hemoglobin concentra
tion analyses. Gastric saline solution was
then withdrawn into a 50-ml syringe and,
when the gastric solution was obviously
bood-stained, 5 ml was withdrawn into a
syringe previously connected to the naso
gastric tube. Oxygen tension and hemoglo
bin concentration were determined.
Rosenberg and Harken found that in all
nine patients with bleeding caused by gas
tritis or ulcer the oxygen tension of gastric
aspirate was 122 mm Hg or higher, and that
in four of five patients with bleeding from
esophageal varices the Poi of gastric as
pirate was less than 100 mm Hg.
Although this test was used in few pa
tients it may prove to be a useful noninvasive test to differentiate variceal bleed
ing from bleeding resulting from gastritis or
ulceration.
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MYOCARDIAL INFARCTION AFTER AORTOCORONARY BYPASS:
ETIOLOGIC FACTORS*
)

R ALLARD, MD, FRCS[C], C. A. MILNE, MD, FRCS[C], N. L. POIRIER, MD, FRCS[C],
A. SNIDERMAN, MD, FRCP[C] and J. E. MORIN, MD, FRCS[C]

To ascertain the frequency and probable
determinants of myocardial infarction after
aortocoronary bypass, two groups of patients
were studied: a group of 20 patients who under
went valve replacement or repair of congenital
anomalies and a group of 24 patients who un
derwent aortocoronary bypass. Postoperative
myocardial infarction was diagnosed by an in
crease in serum creatine phosphokinase con
centration to a minimum of 1200 IU in two con
secutive samples.
The frequency of myocardial infarction dif
fered between the groups, being only 5 % in
group 1 but 20.4% in group 2. In the patients
undergoing coronary artery surgery, the duration
of bypass, the aortic cross-clamp time and the
vent site did not influence the rate of infarction.
However, the incidence of myocardial necrosis
did correlate with the number of vessels by
passed. In no case was the clinical course in
fluenced by the infarction.
Our results suggest that the frequency of
perioperative infarction is higher in coronary
artery surgery than in other adult cardiac sur
gery, and that the most important determining
factor is the number of diseased vessels.
Nous avons evalue la frequence et les facteurs qui peuvent predisposer a I'infarctus du
myocarde apres les pontages aortocoronariens.
Deux groupes furent etudies: le premier groupe (20 patients) a subi soit des remplacements
valvulaires soit des corrections d’anomalies congenitales. Le deuxieme groupe (24 patients)
a subi des pontages aortocoronariens. Le dia
gnostic d’infarctus du myocarde a ete pose,
lorsqu'il y avait une elevation anormale de la
CPK.
L’incidence des infarctus du myocarde differe
dans les deux groupes. Elle est de 5% dans le
premier groupe mais de 20.4% dans le second.
Chez les patients ayant subi un pontage aortocoronarien, la duree de la circulation extracorporelle, le temps de pincement de I’aorte et la
localisation de la ligne de decompression ven-

*From the division of cardiovascular and thoracic
surgery, McGill University and Royal Victoria
Hospital, Montreal, Que.
Presented at the annual meeting of the Canadian
Cardiovascular Society, Montreal, Que., Oct. 2325, 1975.
Reprint requests to: Dr. Jean E. Morin, Depart
ment of surgery, Royal Victoria Hospital, 687
Pine Ave. W, Montreal, PQ H3A 1A1.

triculaire gauche n'ont pas influence I'incidence
d'infarctus. Cependant, la frequence de necrose
myocardique etait proportionnelle au nombre de
pontages pratiques. Devolution clinique des pa
tients en periode post-operatoire n'a pas ete
influencee par la presence de ces infarctus.
Nos resultats suggerent que la frequence de
I'infarctus du myocarde peri-operatoire est plus
grande chez les patients subissant des pontages
aortocoronariens que chez les patients adultes
operes pour d'autres pathologies cardiaques, et
le facteur qui influence le plus I’incidence des
infarctus du myocarde est le nombre de vaisseaux atteints de facon significative par le pro
cessus artherosclerotique.

T h e postoperative diagnosis of myocardial

infarction (MI) may be difficult.1 Chest
pain, a cardinal symptom of infarction, may
be obscured by concomitant incisional pain
or obtunded by analgesics, and elevation of
serum enzymes may result from surgical
trauma.- Detection of myocardial necrosis
is particularly difficult after cardiac surgery,
because direct manipulation of the heart
and pericardium can produce an epimyopericarditis, which may cause pain, and elec
trocardiographic changes suggesting MI.
The aim of coronary artery surgery is to
preserve myocardial tissue, and one indica
tor of its success is the incidence of MI
following surgery. We therefore set out to
determine the incidence of MI after aorto
coronary bypass, noting particularly whether
the conduct of the operation altered the
frequency of infarction.
P a tien ts and M ethods

Forty-four patients (22 men, 22 women)
undergoing cardiopulmonary bypass were
divided into two groups according to the
nature of the surgical procedure: The 20
patients in group 1 (mean age, 48 years) in
cluded all those undergoing either valve
replacement, open mitral commissurotomy
or repair of a congenital anomaly. The 24
patients in group 2 (mean age, 50 years)
had coronary artery disease; at least one
aortocoronary bypass procedure was per
formed in each patient. The diagnosis and
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TABLE I.—D iagnoses and Operative P roce
dures P erformed in 44 P atients U ndergoing
C ardiopulmonary B ypass
Group
1
2
{n = 20) 0n = 24)
Diagnosis
M itral valve disease....
Aortic valve disease.. . .
Atrial septal defect. . . .
Coronary artery disease
Procedures
M itral valve replace
ment ............................
Aortic valve replace
m ent............................
Double valve replace
ment ............................
Open mitral commisurotom y........................
Repair of atrial septal
defect..........................
Aortocoronary bypass
x 1................................
Aortocoronary bypass
x 2 ................................
Aortocoronary bypass
x 3 ...............................
Aortocoronary bypass
x 4 ...............................
Internal mammary ar
tery to left anterior
descending coronary
artery ..........................

9
7
4
—

—
—

24

6
6
1

R esults

Incidence of Infarction
In group 1 (patients undergoing valvular
surgery or repair of congenital anomalies)
only 1 of the 20 patients sustained MI.
In contrast, in group 2, 5 of 24 pa
tients receiving aortocoronary bypass sus
tained MI. None of the patients with post
operative infarction died, nor did they suffer
from a low cardiac output state or conges
tive heart failure. Clinical recovery in the
immediate postoperative period was evi
dently not affected by infarction.
Enzyme and ECG Results

3
4
4
7
—

Vol. 19

9
3

1

details of various operative procedures are
listed in Table I.
Serum enzyme concentrations and elec
trocardiograms (ECG) were obtained in the
48 hours before operation and at the fol
lowing times after operation: immediately
the patient reached the recovery room, 10
hours later and on days 1, 2, 3, 5, 7 and 10.
On each serum sample, serum glutamic oxa
loacetic transaminase (SGOT), lactic dehy
drogenase (LDH) and creatine phosphokinase (CPK) values were determined by
standard automated techniques. The anal
yses of the ECGs were made independently
of results of the enzyme studies.
The major criterion for infarction in this
study was an elevation of CPK to a mini
mum of 1200 IU on at least two consecu
tive determinations.'* The ECG was con
sidered diagnostic of transmural infarction
if it showed new persistent Q waves, and
was considered compatible with ischemic in
jury if localized, characteristic, ST-segment
deflections were recorded. Pericarditis was
diagnosed if classical evolution of ST-T
segments was documented.

The CPK concentration was elevated in
all six patients with infarction to at least
1200 IU on 2 consecutive determinations.
Only one patient had associated ECG evi
dence of transmural infarction.
Changes in SGOT and LDH did not pa
rallel those of CPK. For SGOT 100 IU was
taken as the upper limit of normal follow
ing cardiac surgery.4 Only three of the six
patients with infarction had elevated SGOT
levels, but 7 of the 38 patients without in
farction had abnormally elevated levels.
Similarly an LDH value less than 500 IU
was not accepted as evidence of necrosis.4’ 5
In only two patients with infarction was the
LDH elevated; again 7 patients without
other evidence of infarction had an elevated
LDH.''- ‘
The ECG findings are summarized in
Table II. In the preoperative ECG the fre
quency of old MI was 10% in group 1 and
40% in group 2. The ECG findings in the
six patients with MI, diagnosed by CPK,
varied. In only one patient did definite evi
dence of transmural infarction develop.
Another had an ST current of injury. The
dominant finding in the rest was ST-T
changes that, although indicating ischemia,
were not sufficiently specific that subendo
cardial infarction could be diagnosed by
conventional criteria.
Two noteworthy findings were that some
patients with similar ECG changes did not
manifest sustained rises in serum CPK, and
that the incidence of postoperative pericar
ditis following coronary artery surgery is
high compared with other forms of cardiac
surgery.
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TABLE II.—E lectrocardiographic C hanges

aortic, cross-clamp time in patients with
infarction (28 ± 8 min) and those without
infarction (27 ± 4 min) (P > 0.50). Again,
comparison of cross-clamps exceeding 15
minutes revealed no significant difference
between the two groups; in four patients
with infarction no period of cross-clamping
exceeded 15 minutes while four patients
without infarction had two periods of cross
clamping for more than 15 minutes.

Group
Abnormality
Preoperative:
Old myocardial
infarction...................
Postoperative:
QRS changes (Q
waves)*......................
QRS changes (bundle
branch block)............
ST-T changes of injury*
ST-T changes of
ischemia)....................
ST-T changes of peri
carditis* ......................
Nonspecific ST-T
changes*.....................

1
(n = 20)

2
(n = 24)

2

10

0

1

4
0

0
2

3

7

4

9

9

1

Vent site during cardiopulmonary bypass.
— In only 4 of the 24 patients was a vent
not placed and none of these had MI. In
the remainder the location of the vent
varied, being either in the apex of the left
ventricle (12 patients) or through the left
atrium (8). The number of infarctions was
evenly distributed—three in the former
and two in the latter— making the vent
location an unlikely determinant of infarc
tion.
When the actual increase in serum CPK
concentration was compared in patients
whose heart was vented through the apex
of the left ventricle and in the others, there
was no significant difference (P > 0.20).
In 16 of the 20 patients in group 1 a vent
was also placed through the apex of the left
ventricle and their serum CPK concentra
tion was not abnormally elevated.

*One patient in this category had an infarct.
(Two patients in this category had an infarct.

Factors Relating to Incidence of M l in
Aortocoronary Bypass
Duration of bypass.— It appears that
cardiopulmonary bypass beyond 2 hours
may increase the risk of infarction (Table
III). Indeed, of 11 patients on bypass longer
than 2 hours, 4 sustained infarctions; of 13
with bypass for shorter time periods, only
1 had an infarct. Yet the duration of bypass
was clearly related to the complexity of the
peration. Of the 11 patients with pump
times exceeding 2 hours, 7 had at least three
vessels bypassed. Conversely eight patients
with pump times of less than 2 hours re
quired at most two bypasses. When the
mean duration of cardiopulmonary bypass
in both groups was compared, we noted no
significant difference: 115 ± 15 min in pa
tients without infarction and 138 ± 2 7 min
in those with infarction (P > 0.50).
Aortic cross-clamp time.— There was no
significant difference in the mean, total,
TABLE I II .—D uration

of

Bypass

v.
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Number of bypasses performed.— There
was a clear relation between the frequency
of infarction and the number of bypasses
performed. In the five patients with a single
bypass no infarctions occurred. The inci
dence of MI increased with the number of
bypasses constructed. One of seven patients
with two bypasses sustained an infarction
whereas this complication occurred in three
of nine patients with three bypasses and in
one of three patients with four bypasses.
I ncidence

of

M yocardial I nfarction

No. of vessels grafted
No. of
patients

Duration, min
1 — 60 ........................
61 — 120........................
121 — 180........................
181 — 240........................
241 — 300........................

........
........
........
........
........

4
9
7
3
1

1
4
1

2

O

3
4

5
1
3

4

MI

2

0
(3)*
(4), (2), (2)
(3)
0

1

*Each set of parentheses represents one myocardial infarction; the number within each set of parentheses re
presents the number of vessels grafted in that patient.
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D is c u s s io n

This study indicates a definite risk of
MI after aortocoronary bypass surgery.
The risk is clearly higher in these circum
stances than in other types of cardiac sur
gery. Yet the clinical importance of our find
ings is not clear. Certain reservations must
be stated before reaching such conclusions.
We recognize that the diagnosis of MI
after cardiac surgery is difficult.2 Cases
in which classical ECG changes of localized
transmural infarction appear, present no
difficulty. Fortunately in our experience
this was relatively rare. The criterion relied
on in this study was a serum CPK con
centration greater than 1200 1U on two
consecutive determinations. This cutoff
point is based on the study of Bolooki
and associates,2 who demonstrated that all
such patients had occluded vessels or new
areas of hypokinesis on follow-up examina
tion.
In our study only total serum CPK was
measured. Skeletal muscle necrosis liberates
CPK into the serum,2 yet the measurement
of the myocardial isoenzymes may not sub
stantially improve the diagnosis of postoper
ative infarction.8 The additional sophistica
tion may be illusory because such surgery
involves direct manipulation of the heart.11
The pericarditis so often seen testifies to
probable epicardial damage.
Patients who did not have coronary artery
surgery rarely had a diagnostic increase in
the serum CPK concentration. Such patients
did not have coronary artery disease so a
relatively low incidence of infarction would
be anticipated. It suggests that a CPK con
centration greater than 1200 IU probably
indicates myocardial necrosis and would not
be anticipated on the basis of the surgical
procedure alone.
The bias of this study is pessimistic. The
ECG confirmed MI in only one of the six
cases. If anything, therefore, we may over
rather than underestimate our frequency
of infarction. The incidence of infarction
considering the rather small numbers in
each group is compatible with that reported
by others.3'8' 10‘13
Opinions have differed as to the impor
tance of bypass time longer than 120 min
utes.8' 10 We found no indication that this

V ol. 19

was an independent determinant. The clear
est factor that influenced the risk of infarc
tion was the most obvious: the number of
bypasses performed is related to diffuse
ness of disease, and as the extent of disease
increases so does the risk of infarction.r)1 0 , 14

In our series MI did not influence the
clinical outcome, contrary to the findings
noted after other forms of surgery.3- 5' 7- 8'
1;{. 14 This does not mean that MI is
unimportant, but that there is no serious
risk in the immediate postoperative period.
C o n c l u s io n s

The incidence of MI after aortocoronary
surgery is greater than that after noncoro
nary cardiac surgery. Of all the possible
contributing factors analyzed, only the num
ber of vessels bypassed had a direct correla
tion with the incidence of MI. In patients
with infarction, there was no discernible
effect on recovery, so the clinical importance
of infarction in this period is not clear. Our
understanding would be improved by more
sensitive and specific tests to recognize myo
cardial necrosis in the postoperative period.
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SURGICAL REPAIR OF ACUTE VENTRICULAR SEPTAL DEFECT
COMPLICATING MYOCARDIAL INFARCTION*
JOHN C. COLES, MD, FRCSjC], FACS, W. G. SANDOVAL, MD, A. DOCTOR, MD,
FRCS(Edin), FRCSjC] and C. MULLANGI, MD
Ventricular septal defect complicating myo
cardial infarction was repaired surgically in
seven patients between 1965 and 1974. In four,
the septal defect had developed in the lower
portion of the septum and in three, high in the
septum, above the origin of the papillary muscle.
Concomitant operations included mitral valve re
placement and infarctectomy, in one patient, and
triple aortocoronary bypass in another. The com
moner low defect was repaired either by ampu
tating the lower portion of the heart or patch
repairing through a left ventriculotomy incision.
The higher defects, more difficult to repair, were
repaired through a high posterior left ventricu
lotomy. Complete pre- and postoperative hemo
dynamic studies were carried out and follow-up
information was available for all patients.
Recognition of the high defect is essential.
Pathologically, the coronary artery lesion is
more complicated and extensive and a different
surgical approach is necessary. A classification
of high and low ventricular septal defects de
veloping after myocardial infarction is recom
mended. The natural history of the disease and
the reasonable surgical results support an active
surgical approach in both types of postinfarction
septal perforation.

^'Presented at the annual meeting of the Cana
dian Cardiovascular Society, Montreal, Que.,
Oct. 23-25, 1975.
Reprint requests to: Dr. J. C. Coles, Chief, Car
diac surgery, Victoria Hospital, 391 South St.,
London. ON N6A 4G5.

Entre 1965 et 1974, on a fait chez sept patients
la refection chirurgicale de communications
interventriculaires survenant en cours d’infarctus du myocarde. Dans quatre cas, la com
munication interventriculaire est apparue dans
la partie basse du septum et dans trois cas, elle
etait haute, au-dessus de I'origine du muscle
papillaire. Les operations concomitantes ont
compris le remplacement de la valvule mitrale
et une infarctectomie chez un patient, et un
triple pontage aortocoronarien dans un autre
cas. La communication interventriculaire basse,
plus frequente, a ete corrigee soit en amputant la partie inferieure du coeur, soit par
occlusion en passant par I'incision d'une ventriculotomie gauche. Les communications inter
ventriculaires hautes, plus difficiles a reparer,
ont ete corrigees par une ventriculotomie posterieure gauche haute. Des etudes hemodynamiques completes ont ete realisees dans la periode pre- et post-operatoire et I'information de
post-observation a ete obtenue pour tous les
patients.
La reconnaissance des communications inter
ventriculaires hautes est essentielle. Pathologiquement, la lesion de I'artere coronaire est
plus compliquee et plus etendue et elle requiert
une approche chirurgicale differente. II est
recommande qu'on fasse la classification des
communications interventriculaires hautes et
basses consecutives a un infarctus du myo
carde. L'evolution normale de la maladie et les
resultats chirurgicaux satisfaisants obtenus
vont a I'appui d'un traitement chirurgical actif
dans les deux types de perforations septales
consecutives a un infarctus.
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Septal perforation, first described by La
tham 1 in 1845, is an uncommon but sinister
complication of myocardial infarction that
occurs in approximately 0.5% of all cases
of infarction and is responsible for 2% of
all fatal cases.2- 3 The true incidence, how
ever, may be higher because the lesion may
be missed, even at autopsy with the heart
in an agonal state. This is particularly a p 
plicable to the high defect.

The natural history of postinfarction
septal perforation suggests an extremely
poor prognosis in patients treated medical
ly, for 65% are dead within 2 weeks and
80% within 1 month, and only occasional
patients survive for 1 year.4 This survival
is in sharp contrast to that for patients
treated surgically: Javid and associates,5 for
example, reported that 60% were alive and
well at 1 month and 32% alive after 1 year.
Since the first reported surgical closure
by Cooley and colleagues6 in 1957, there
have been numerous case reports of surgi
cal repair, but no one institution has accu
mulated a large experience. Useful contribu
tions are those of Kitamura, Mendez and
Kay,7 Shumacker,8 Donahoo and asso
ciates6 and Shumway.10 According to most
of these authors, including Shumacker8 and
Donahoo’s group,0 early operation mitigates
against success. This, however, has not been
the experience of Shumway10 nor of our
selves in a small series of patients.
Diagnosis is made when a loud systolic
murmur develops early in the course of
acute myocardial infarction. This is almost
invariably associated with congestive heart
failure. Papillary muscle rupture may pre
sent difficulty in the differential diagnosis
but the echocardiogram will readily dif
ferentiate this.11 The clinical diagnosis is
confirmed by a catheter-angiographic study
demonstrating the site and location of the
usually large left-to-right shunt.
In this paper we present our experience
at the University of Western Ontario with
the surgical treatment of postinfarction sep
tal perforation, propose a classification of
such defects, bring attention to the high de
fect occurring above the origin of the pa
pillary muscle, and describe a surgical ap
proach to this latter type of defect.

Patients

and

M ethods

During a 13-year period (1962 through
1974), seven patients with septal perfora
tion complicating myocardial infarction un
derwent operation for surgical repair. Cer
tain details of the patients, their condition
and the outcome are presented in Table I.
TABLE I.—D etails of Seven P atients with
Ventricular Septal P erforation C omplicating
M yocardial I nfarction

Sex, age (yr)
M
F
M
M
M
F
M

,48
, 56
, 77
, 64
, 67
, 79
, 67

Interval,
diagnosis
to operation
(4)
8 — 89
11 — 19
4 — 34
5 — 21
10 — 12
2 — 4
7 — 11

Type of
defect
Low
Low
Low
High
High
High
Low

Outcome
Died at 6 yr
Well at 1 yr
Died at 29 d
Well at 2 yr
Well at 18 mo
Died at 11 d
Died at 24 h

The ages of the five men and two women
ranged from 48 to 79 years. The diagnosis
was made 2 to 11 days after the myocardial
infarction and operation was performed be
tween 4 and 89 days after the infarction.
In three patients the defect was a high one
and in four, a low one.
Surgical Technique
Since Cooley and colleagues6 described
their procedure in 1957, the conventional
approach has been through an anterior
right ventriculotomy. Kitamura, Mendez
and Kay,7 noting the frequency of antero
lateral aneurysm or infarct, suggested a left
anteroapical ventriculotomy, a second ad
vantage being the distinct marginal defini
tion unobstructed by the heavily trabeculated right ventricle; Javid and colleagues5
suggested a similar approach. Shumacker,8
who noted the difficulty in repairing the
most posterior defects, suggested a posterior
right ventriculotomy approach.
We have used the following technique:
The low or conventional defect was ap
proached through a right ventriculotomy in
one patient, a left ventriculotomy in two
and resection of the apex of the heart in
one. The high defects were all approached
through a high posterior left ventriculotomy,
gentle forward retraction of the chordae
tendinae giving a clear visualization of the

M arch 1976

THE C A N A D IA N J O U R N A L OF SURGERY

145

Fig. 1.—Exposure of high ventricular septal
defect.

edge of the defect (Fig. 1), which would
otherwise be difficult with the more con
ventional ventriculotomies.
Use of a generous patch of Dacron or
Teflon and its fixation with numerous
Teflon felt-buttressed sutures well away
from the apparent edge of viable muscle is
mandatory.
Associated left ventricular aneurysm or
infarcted muscle must be excised,12 16 and
the judicious use of an aortocoronary by
pass graft may make the difference between
success and failure in patients whose con
dition is borderline.
The high ventricular septal defect pre
sents certain peculiarities that require em
phasis. These peculiarities are as follows:
The high defect is funnel-shaped and transverses the septum obliquely, presenting on
the right ventricular side at a lower level
(Fig. 2). It lies above the papillary muscle,
in contrast to the conventional defect. In
our three patients, all had evidence of pre
vious myocardial infarction high in the
posterior wall of the left ventricle; this is
in contradistinction to the situation in those
with the conventional low defect, who often
had no prior evidence of coronary artery
disease.
Further, with respect to the pathologic
features and compared with the low defect
(in our experience), the coronary arteries
manifest certain differences in cases of the
high defect, the left anterior descending

Fig. 2. —Features of high and low types of ven
tricular septal defects.

coronary artery being patent and both the
right coronary artery and the circumflex be
ing occluded or severely diseased.
Finally, there is no associated ventricular
aneurysm, though akinesis of the upper part
of the posterior wall of the left ventricle was
a feature in two of our three patients. Left
posterior hemiblock seems to be an inevit
able complication of the high defect. Con
comitant surgical procedures included aorto
coronary bypass grafting, mitral valve re
placement, aneurysmectomy and infarctectomy.
R esults

Four of the seven patients left hospital
alive, and, when last seen, three of them
were well at 18, 24 and 27 months; the
fourth died suddenly 6 years after opera
tion. Two of the others have a residual leftto-right shunt that does not seem hemodynamically important (1.2:1 and 1.3:1), and
two have a posterior hemiblock.
The three hospital deaths occurred on the

146

THE CANADIAN JOURNAL OF SURGERY

1st, 11th and 29th postoperative day, re
spectively. The first patient barely survived
the operative procedure and died within a
few hours despite intensive respiratory,
mechanical and pharmacologic support.
The second was well until the 4th day, when
congestive heart failure again became evi
dent. A systolic murmur recurred on
the 5th day and her condition slowly but
progressively deteriorated. Reopening of
the defect was suspected. Autopsy revealed
two small openings (diameter, 1.5 and 2
mm) at the edge of the patch.
Fresh thrombus was present in all three
aortocoronary bypass grafts but the lumi
nal diameter was not compromised at any
of the anastomotic sites. Presumably this
was an example of premortem thrombosis in
situ without obvious main vessel occlusion.
The third patient who died had insidious
but progressive congestive heart failure and
low cardiac output. The defect was com
pletely closed.
D iscussion
Ventricular septal defect as a conse
quence of myocardial infarction is uncom
mon. The prognosis is poor. Early diagnosis
and surgical closure are warranted on the
basis of all available data. Early and long
term survival depend on the extent of mus
cle death. Operation performed 6 weeks,
or longer, after the diagnosis— aided by
the process of natural selection of the fit
test, as well as the clearly defined fibrotic
edge of the defect—carries a lower mor
tality and the incidence of recurrence of the
left-to-right shunt is lessened.2'
17' 21 On
the other hand, early operation is often
necessary as, otherwise, the majority of pa
tients will have already died.22' 29
It is important to monitor the condition
of patients with this complication carefully.
Should a patient’s condition be hemodynamically stable, operation is delayed for a
minimum of 6 weeks. Should any deteriora
tion occur, the site and size of the ventri
cular septal defect and the state of the coro
nary arteries is confirmed with balloon
counterpulsation support if necessary, and
an operation performed as an emergency.
The ventriculotomy incision depends on the
site of the defect.

Vol. 19

C onclusions and R ecommendations
Ventricular septal defect following myo
cardial infarction carries a sinister progno
sis. The diagnosis is readily made clinically
and confirmed by catheter-angiographic
study. Surgical closure of the defect carries
a high but acceptable mortality; the mor
tality is still lower than that of patients
treated medically.
We recommend that a classification of
ventricular septal defect as a complication
of myocardial infarction with high and low
types be adopted. The high defect is a sepa
rate entity anatomically and pathologically,
and the patients’ best interests are served
by a different surgical approach.
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Toute communication initiale doit etre adressee au Coredacteurs, CP 8650, Ottawa, On.
K 1G 0G8 sous la mention: “Le journal cana-

dien de chirurgie”.
Manuscrits. Les texts originaux des articles
et des autres communications y compris un
nombre limite de rapports sur des cas speciaux doivent etre rediges en double exemplaire, en frangais ou anglais, et accompagnes
d’une lettre demandant leur publication dans
le Journal. Veuillez les dactylographier sur une
seule face d’une feuille norm al avec double
interligne et grandes marges.
Illustrations. Les illustrations telles que des
photographies d ’appareils cliniques, des radiographies, des photomicrographies, des graphiques et des digrammes doivent etre fournies sous la form e d’epreuves sur papier glace
sans montage, les bordures intactes, d ’un form at
ne depassant pas 12 x 17 cm. Chaque illustra
tion doit etre munie d’une legende dactylographiee sur une page separee du texte de
l’article. S’il s’agit d’une photom icrographie,
expliquez le contraste et 1’echelle de l’agrandissement. Les lettres qui servent a identifier
les elements d ’une illustration doivent etre d’u
ne dimension suffisante afin de dem eurer visi
bles lorsque les necessites de l’impression imposent une reduction de l’image fournie. II
ne faut pas qu’on puisse identifier un patient
grace a une illustration a moins qu’il n ’y ait
expressement consenti par ecrit; faute de per
mission les traits de sa physionomie doivent
etre obliteres. Les illustrations en couleur ne
seront publiees qu’aux frais de leur auteur.
Si l’illustration provient d’une autre source que
celle de l’auteur, il convient d ’obtenir tant de
l’auteur que de l’editeur de l’ouvrage dont elle
est tiree, 1’autorisation de s’en servir aux fins
de la publication.
Tables. Il faut en les etablissant se conform er
au format rectangulaire du Journal et les
rediger sur des feuilles separees du texte, une
table par feuille.
References. Celles-ci doivent etre citees dans
le texte au moyen d’un chiffre et groupees
dans l’ordre a la fin de votre article en vous
conformant a la maniere de faire adoptee par
ce Journal. Les references a des periodiques
doivent etre conformes a celles qu’adopte

YIndex Medicus.
Un resume qui ne doit pas depasser 125 mots
doit accompagner chaque article sur une page
separee.
Une epreuve en placard sera adressee a l’auteur de l’article avant sa parution; on ne peut
autoriser que de legeres retouches. Ce n’est
qu’au moment de restituer ces epreuves d’auteur au Journal qu’il y aura lieu de passer
commande de reimpression.
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Trasylol® was shown to reduce mortality in acute pancreatitis to a significant*
extent:
Placebo................................................ 25.0% Mortality
Trasylol®...............................................
7.5% Mortality
“ Because the number of deaths were reduced, the spectrum of the disease
as a whole was altered.” *
Trapnell’s recent double-blind clinical trial
involving 105 patients confirmed the
effectiveness of Trasylol in acute
pancreatitis. In addition to reducing
mortality and altering the spectrum of the
disease, Trasylol largely abolished the usual
effect of increasing age in this condition.
Trasylol should be given concurrently with
usual measures for the treatment of
pancreatitis, such as pain relief,
fasting, gastric suction, etc. “ It
(Trasylol) can therefore now be
regarded as a drug which is both
effective and beneficial in the
treatment of acute pancreatitis.” *
*Trapnell, J.E. et al, British
J. Surg., March 1974.
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Trasylol, in its role as an
antifibrinolytic agent, inhibits
both plasmin and the
plasminogen activator.

Fibrinogen
Trasylol

Factors V, VIII
Kininogens

Synthetic antifibrinolytic
agents inhibit only the
plasminogen activator,

is indicated for primary and generalized, secondary
hyperfibrinolytic hem orrhages with and w ith o u t the shock
syndrom e. Secondary hyperfibrinolysis follo w in g
intravascular clotting may require heparin a n d /o r
fibrin og en replacement in addition to Trasylol.
W ith Trasylol, the an tifibrin olytic agent w ith
sim ultaneous anti-coagulant (a n ti-th ro m b o p la stic)
effect, there w ill not be a dangerous shift
in the eq uilibrium between
the clotting and the lysis system
in favour of coagula tion.
Synthetic a n tifib rin o ly tic s
are contraindicated if there is
evidence of active intravascular
coagulation. Trasylol is indicated
in all cases of hyperfibrinolysis,
whether a diffe ren tial diagnosis
has been made or not.
FBA Pharmaceuticals Ltd.
Distributed by:
Boehringer Ingelheim (Canada) Ltd.
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Trasylol
• increases the chances
of survival in acute
pancreatitis
• prevents the enzymatic
release of toxic
polypeptides and kinins
• stops hyperfibrinolytic
hemorrhage
Indications and Dosage

Hyperfibrinolytic Hemorrhage
T h e s e c o n d itio n s o c c u r in s u rg e ry ,
including open heart surgery, prostatic
s u rg e ry and p a th o lo g ic a l o b s te tric a l
bleeding conditions, such as in abruptio
placentae.
Initial dosage: 200,000 — 500,000 K.I.U.
of w hich 200,000 K.I.U. should be given
by intravenous injection (a t a rate not to
exceed 5 ml per minute), the rest if neces
sary by slow infusio n. A d m in istra tio n
sh o u ld be co n tin u e d up to 1,000,000
K.I.U. per day until the hemorrhage has
been arrested.

Pancreatitis
Initial dosage: 100,000 — 200,000 K.I.U.
to be follo w e d by 100,000 K.I.U. every
six hours fo r a period of 4-5 days. The
drug is adm inistered either by intraven
ous in je ctio n (a t a rate not to exceed 5
ml per minute) or by slow infusion.
Warnings and Precautions
T rasylol is a polypeptide and thus may
act as an antigen. Although adverse reac
tions due to hypersensitivity have been
described infrequently, this possibility
should always be kept in mind. In patients
w ith a h is to ry o f h yp e rse n sitivity, the
usual precautions for the prevention and
a rre s t o f a lle rg ic re a c tio n s should be
observed p rio r to the adm inistration of
Trasylol.
Availability
Trasylol (aprotinin) is available in 10 ml
a m p u ls c o n ta in in g 1 00,000 K .I.U . in
boxes of 5 ampuls.
Trasylol® Product Monograph is available
on request.

The object of

Trasylol:
Control of proteolytic enzymes.
FBA Pharmaceuticals Ltd.

Distributed by:
Boehringer Ingelheim (Canada) Ltd.
2121 Trans Canada Highway, Dorval, P.Q. H9P1J3
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ENZYME ANALYSIS OF
PERITONEAL BLOOD
IN ABDOMINAL INJURY
Analysis of peritoneal fluid is often useful
in the differential diagnosis of abdominal
disorders. Delaney, Moss and Carnevale
(Surg Gynecol Obstet 142: 161, 1976) have
used this approach in the management of
patients who have sustained abdominal
trauma. They determined the concentrations
of alkaline phosphatase (AP), lactic dehy
drogenase (LDH), glutamic oxaloacetic
transaminase (GOT) and creatine phosphokinase (CPK) in blood withdrawn from the
peritoneal cavity and related these concen
trations to those for peripheral blood.
Blood samples were taken from the perito
neal cavity at operation before irrigation or
manipulation of injured viscera; peripheral
blood specimens were obtained at about the
same time. They identified differences in
enzyme concentrations between organrelated peritoneal blood and related the
findings to the final clinical diagnoses in 70
patients.
Isolated injuries of the liver were asso
ciated with significant increases in LDH
values in peritoneal blood and GOT values
in peritoneal and peripheral blood. Multiple
intra-abdominal injuries produced increased
LDH and GOT values in peritoneal blood.
Isolated injury of the small intestine and
this injury combined with injury of another
organ were associated with significant in
creases in GOT, LDH and AP values in
peritoneal blood.
The elevation of AP concentration in
peritoneal blood was associated with normal
mean values in peripheral blood, and this
abnormality of peritoneal blood was the
most consistent enzyme elevation related to
organ injury, particularly of the small in
testine. Combined AP values in peritoneal
and peripheral blood samples were there
fore of value in identifying small intestine
injuries in patients with traumatic hemoperitoneum.
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SYNOVIAL CHONDROMETAPLASIA: REVIEW OF WORLD LITERATURE
AND A STUDY OF 18 CANADIAN CASES*
ANTONI TRIAS, F R C S [C ]f and OCTAVI QUINTAN A J
A retrospective study of synovial chondrometaplasia in Canada revealed 18 well-docu
mented cases of this condition. Review of
these cases together with 137 cases obtained
from the literature permitted clarification of the
clinical, radiologic and histologic features of the
disease. Positive histologic proof of synovial
chondrometaplasia is necessary for a true diag
nosis. Synovectomy with excision of loose
bodies is the treatment of choice in symptomatic
cases.
Une etude retrospective de la chondrometaplasie synoviale au Canada a revele 18 cas
bien documentes de cette affection. Une revue
de ces cas et de 137 autres releves dans la litterature a permis de clarifier les caracteristiques
cliniques, radiologiques et histologiques de cet
te maladie. Un diagnostic exact doit reposer sur
une preuve histologique de chondrometaplasie
synoviale. La synovectomie accompagnee d'une
excision des arthrophytes constituent le traitement de choix dans les cas symptomatiques.

A n u m b e r of uncertainties affect our under
standing of synovial chondrometaplasia. The
condition is described under several differ
ent terms, there is no consensus concerning
the cause, and the clinical features vary with
the pathologic features. We therefore re
viewed the clinical, radiologic and pathologic
aspects of synovial chondrometaplasia as
described in the world literature and in a
survey of Canadian cases.
T e r m in o l o g y

an d

D ia g n o st ic

C r it e r io n

Because of its similarity to a number of
other conditions arx because of the diversity
of etiopathogenic theories, synovial chon
drometaplasia is known by several synonyms:
‘“Sponsored by the Canadian Orthopaedic Re
search Society and supported by a grant from the
Canadian Orthopaedic Foundation.
{Chairman, department of orthopedics, Centre
Hospitalier Universitaire, Universite de Sherbrooke,
Sherbrooke, Que.
{Summer medical research student, faculty
medicine, Universite de Sherbrooke.

of

Reprint requests to: Dr. A. Trias, Chairman, De
partment of orthopedics, Centre Hospitalier Uni
versitaire, Universite de Sherbrooke. Sherbrooke.
PQ JIH 5N4.

osteochon dritis dissecans, well defined since
Konig’s description1 and still reported as
synovial chondrometaplasia; loose bod ies,
though this is too imprecise a term; synovial
chondrosis, sometimes used by the French
and Italians and implying a degenerative ex
foliative origin; and articular ecchon drosis,
synovial chondrom atosis and osteo ch o n d ro 
m atosis, all assuming a benign neoplastic
origin. Synovial chondrom etaplasia, how
ever, is preferred because it emphasizes cur
rent thinking on the pathogenesis of this
condition, that is, the form ation o f cartilage
from the synovium by m etaplasia.
Although the radiologic appearance of
the joint or the postoperative examination
may suggest synovial chondrometaplasia,
the true diagnosis of this condition rests in
Jaffe’s definition that histologic proof of
cartilage production in the synovium is
necessary.2 We used this diagnostic essen
tial as a criterion for inclusion or exclusion
of cases in our review.
R

e v ie w

of

W

o r ld

L

it e r a t u r e

We reviewed more than 300 papers3 and
classified the published cases but retained
only those that fulfilled our diagnostic cri
terion. There were 137 such cases. However,
it is difficult to state with certainty that all
were genuine cases of synovial chondrome
taplasia as in some cases we had to rely on
unverified information; for instance, histo
logic formation of cartilage from the syno
vium was reported for all 137 cases, but
often it was impossible for us to check the
reported observations.
R

e v ie w

of

C an adian C a s e s

Because the international nomenclature
used by most hospitals does not specifically
code synovial chondrometaplasia, our only
source of Canadian cases was the member
ship of the Canadian Orthopaedic Associa
tion. Of the 122 case reports submitted to
us by members of the association, only 50
contained adequate clinical, histologic and
radiologic information. Of these 50 cases,
only 18 fulfilled our diagnostic criterion of
synovial chondrometaplasia. This does not
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mean that of the 122 cases only 18 were
truly cases of this condition. Some appeared
to be genuine but lacked histologic evidence;
others were discarded because, in the ma
terial available, no cartilage production in
the synovium could be seen— and, because
the whole synovium is usually not affected,
our sample might have represented examina
tions of unaffected areas.
E tiopathogenesis
There is still no agreement as to the cause
Fig. 1.—Bilateral chondrometaplasia of knee
of synovial chondrometaplasia. The most joint in two siblings, 7 and 5 years of age.
common causes considered are:
submitted from Canadian sources, the re
1. Infectious— Reichel4 and Rixford3 spective proportions were 68 and 32%, and
believed that infection could stimulate of the cases accepted as being synovial chon
the synovium into chondrogenesis. How drometaplasia they were 61 and 39%. It is
ever, they did not observe an inflammatory generally agreed that the disease occurs most
reaction in the synovium.
commonly between 30 and 50 years of age;
2. Embryologic—Undifferentiated cells
this was true for the world and Canadian
could differentiate into cartilaginous tissue.6 cases, both submitted and accepted.
This possibility, which is based on the meta
Familial Incidence
plastic theory, has often been upheld. The
fact that synovial chondrometaplasia is more
Of the 137 cases obtained from the litera
common between 20 and 50 years of age ture there was a familial occurrence in only
does not favour this possibility.
3 cases. In the Canadian series, three chil
3. Traumatic— Trauma has often been dren in one family suffered from synovial
advanced either as the determining or as a chondrometaplasia (Fig. 1).
predisposing factor. We found that a history
Symptoms
of trauma to the affected joint was either
The knee joint has been reported by all
denied or not reported in more than 50%
authors
to be the most frequent site of
of the world cases and that the proportion
was 67% (12 of 18 cases) in our Canadian synovial chondrometaplasia, followed by the
shoulder and elbow joints, then the hip
series.
4. Neoplastic— The description of Hen joint. However, synovial chondrometaplasia
derson and Jones,7 among others, favours can occur in any joint and has been de
this theory, which would explain the clinical scribed in most. In our series of Canadian
recurrences and the three cases only of cases a similar pattern was apparent (Fig.
malignant degeneration described in the 2), but the differences were not significant
because of the small numbers involved.
literature.
5. Meta plastic—This, the most common
ly accepted theory, was developed first by
Freund,8 on a histologic basis. He classified
the condition as hyperplastic metaplasia, a
concept in between neoplasia and true meta
plasia.
C linical F eatures
Sex and Age Distribution
This condition is at least twice as common
in males as in females. In the world literature
69% of cases occurred in males and 31%
in females; of the cases whose reports were

JO IN T AFFECTED

Fig. 2.—Location o f synovia! chondrometapla
sia. White columns represent Canadian submitted
cases and shaded columns Canadian accepted
cases.
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The duration of symptoms is quite long,
perhaps because none is specific; in more
than 50% of the world and Canadian cases
the duration was more than 2 years (average,
5 years).
Pain is the most frequent symptom (85%
in the Canadian group). Sometimes the pain
is periodic, often it is ill defined and mild
at the onset, gradually becoming worse and
at times incapacitating the patient. The pain
may occur with movement or may be inter
mittent, lasting in some instances a few sec
onds and in others a few weeks. In patients
with advanced synovial chondrometaplasia
the pain may become permanent.
If the loose bodies compress a nerve
(generally the ulnar nerve at the elbow),
the symptoms are those of a peripheral le
sion in the distribution of that nerve.
Swelling and enlargement of the joint are
common (42% of Canadian cases). This
may be due to increased synovial fluid be
cause of synovitis or to the accumulation of
numerous fragments. Robineau9 counted up
to 1200 loose bodies in one joint, and from
one knee Nilsson10 removed 2 kg of loose
bodies.
Limited range of motion is also charac
teristic (55% of Canadian cases). In 5%
of our cases actual blocking of the joint had
occurred. The restriction of movement is
often progressive; it may be permanent or
may be present only during exacerbation.
Atrophy of the muscles controlling the
joint was noted in 21% of the cases in our
Canadian series.
The joint was tender on palpation in 20%
of the Canadian cases; one or more frag
ments could be palpated in another 20%
and crepitus occurring with movement was
often recorded.
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should be relatively healthy. Some authors
have even established a definite number of
loose bodies in the joint that should be
present before a radiologic diagnosis of
synovial chondrometaplasia can be made.
More than five loose bodies were observed
in 55% of Canadian cases. (Generally at
operation many more loose bodies were
encountered than were seen radiologically.)
Loose bodies are often found in other
conditions such as osteochondritis dis
secans, neuropathic joint, trauma and de
generative arthritis; also, synovial chondro
metaplasia can lead to degenerative arthri
tis. Therefore, with our present knowledge
of this condition, we cannot rely entirely
on radiologic findings for the diagnosis.
Tomography may help locate the frag
ments. Arthrography is also useful to visual
ize noncalcified loose bodies. We have used
successfully gas arthrography combined with
tomography.
Pathologic A spects
Macroscopic Findings

In the early stages of synovial chondro
metaplasia the articular cartilage is usually
intact. The synovium appears congested with
enlarged villi (11 % of our cases).
The loose bodies are round with a clear
centre and a shell of calcification. Their
dimension varies, sometimes reaching the
size of a chestnut. Usually they are located

R adiologic A spects

Radiologic examination is perhaps the
most important preoperative examination.
The diagnosis of synovial chondrometaplasia
was suggested radiologically in 85% of
Canadian cases.
Typically, the appearance is of multiple
loose bodies, with varying degrees of calci
fication (Fig. 3). Cruveilhier11 stated that
a diagnostic requirement was that the loose
bodies must be numerous and that the joint

Fig. 3.—Loose bodies with varying degrees of
calcification in knee of 37-year-old man.
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free in the joint but sometimes can be seen
in synovial recesses. Often they appear in
the joint in a typical “grape formation”
(Fig. 4).
Loose bodies within the synovium can be
palpated. Others are pedurculated or free
within the joint. Rarely, extracapsular
loose bodies are found in bursa (Fig. 5).

Vol. 19

formation of numerous, often large villi
(Fig. 7). The stroma is not infiltrated by
inflammatory cells.
There is striking hypervascularity (Fig. 8).
Characteristically, normal synovium con
tains a uniform network of anastomosing

Microscopic Findings
The microscopic features of chondrometapalpated. Others are pedunculated or free
diagnostic importance.
Chondrometaplasia.— Areas of chondrogenesis are found in the subsynovial strata;
that is, between the synovial cell layers and
the fibrous outer layer (Fig. 6). In active
disease, the synovium is hypertrophic with
an increased number of synovial cells and
Fig. 6.—Hypertrophic synovium with large villi
and cartilaginous metaplasia (hematoxylin and
eosin, reduced by 40% from x 25).
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of

1: h m ®

raSt i;

lip'
’

hV '

•
,

1, --i

*

m

%

Fig. 7.—Hypertrophic villi with increasing thick
ness of synovial cell layer (hematoxylin and eosin,
reduced by 40% from x 63).

Fig. 5.—Subacromial bursa with cartilaginous
bodies.

Fig. 8.—Cross-section of villus demonstrates
large central vessels surrounded by numerous sub
synovial capillaries (hematoxylin and eosin, re
duced by 40% from x 160).
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capillaries fed by larger terminal arterioles
and venules. Higher magnification (Fig. 9)
shows patency of pericapillary spaces. We
believe the significance of this vascular
arrangement should be the object of further
study.
Sites of early chondrogenesis are charac
terized by nodular infiltration of round cells
(Fig. 10); several contiguous sites of chon
drogenesis are usually observed (Fig. 11).

These round cells enlarge and acquire the
features of chondroblasts surrounded by
ground substance with chondromucoid histochemical reaction (Fig. 12). Once the
cartilaginous nucleus is formed, it enlarges
by producing more chondroid matrix through
division of the chondrocytes and by appositional growth. The cartilaginous bodies are
surrounded by a fibrous collagenous cap
sule (Fig. 13).

Fig. 9.—Large perivascular spaces of synovial
cells (hematoxylin and eosin, reduced by 40%
from x 250).

Fig. 12.—Large chondrocytes producing chon
droid matrix within villus (hematoxylin and eosin,
reduced by 40% from x 50).

Fig. 10.—Nucleus of chondroid round cells with
in synovial membrane (hematoxylin and eosin re
duced by 40% from x 250).
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Fig. 13.—Cartilaginous nucleus surrounded by
fibrous capsule (hematoxylin and eosin, reduced
by 40% from x 125).
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Fig. 11.—Two contiguous nuclei of chondroid
forming cells (hematoxylin and eosin, reduced by
40% from x 125).
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Fig. 14.—Several intrasynovial cartilaginous
bodies surrounded by fibrous capsule and showing
early signs of resorption and degeneration (hema
toxylin and eosin, reduced by 40% from x 125).
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The cartilage becomes less cellular (Fig.
14), often with areas of degeneration. At
the periphery, zones of chondroclasis are
seen. At this stage nodules of cartilage may
extrude from the synovium into the joint
cavity (Fig. 15). Other cartilaginous bodies
may undergo partial endochondral ossifica
tion resulting in intrasynovial ossicles (Fig.
16).
Quite characteristic are large round cells
(Fig. 17) surrounding degenerating nuclei,
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as if the cartilage could revert to fibrous
tissue by the disappearance of the ground
substance (Fig. 18), leaving the denuded
collagenous fibres with the old chondrocytes
represented by these large cells (Fig. 19).
This results in a large capsule and some
times becomes a fibrous synovial scar (Fig.
20 ).

Fig. 18.—Degenerating cartilaginous body with
large round cells within the surrounding fibrous
capsule (hematoxylin and eosin, reduced by 40%
from x 50).

Fig. 15.—Cartilaginous synovial bodies ready
to extrude into joint cavity (hematoxylin and
eosin, reduced by 40% from x 25).
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Fig. 16.—Ossicle within synovial membrane
(hematoxylin and eosin, reduced by 40% from
x 63).

rrT

HI
Fig. 19.—Collagen fibres in continuity with
chondroid matrix; liberation of chondrocytes (he
matoxylin and eosin, reduced by 40% from x
400).

c

Fig. 17.—Degenerating cartilaginous body with
fibrillation of its peripheral layers and liberation
of chondrocytes (hematoxylin and eosin, reduced
by 40% from x 250).
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Fig. 20.—Enlargement of fibrous capsule with
large round cell (hematoxylin and eosin, reduced
by 40% from x 400).
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Loose bodies.— Loose bodies look similar
to those arising from other conditions (Fig.
21). The larger bodies are heavily calcified,
degenerated and often are osteocartilaginous.
Laminar growth by apposition is readily
seen (Fig. 22).
Although the loose bodies are not gen
erally surrounded by a true capsule, the
cartilage degeneration into fibrous tissue is
also seen at the periphery (Fig. 23).
Usually the whole synovial membrane is
not involved in the chondrogenic metaplasia.
However, chondrogenesis within the syno
vium must be demonstrated before a true
diagnosis of synovial chondrometaplasia can
be established. For those who adhere to this
strict diagnostic criterion, the disease is rare.
N a tu r a l C ourse
Kienbock 1 - described five stages of syno
vial chondrometaplasia:

1. Initially, formation of isolated small
nodules, within the synovial membrane,
which can be seen only histologically.
2. Formation of intrasynovial nodules of
different sizes.

Fig. 22.—Laminar growth of loose body (hema
toxylin and eosin, reduced by 20% from x 25).

Fig. 21.—Typical loose osteocartilaginous body
within joint (hematoxylin and eosin, reduced by
20% from x 250).

Fig. 23.—Fibrous capsule in periphery of loose
cartilaginous body (hematoxylin and eosin, re
duced by 20% from x 125).
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3. Migration of nodules into the joint inadequate. We had to discard many Cana
cavity.
dian cases that were perhaps genuine but
4. Depletion of loose bodies in the cap for which we did not have enough data; this
sule with destruction of bone and articular emphasizes the weaknesses of retro
cartilage.
spective studies and the need to develop
5. Complete disintegration of the joint.
valuable prospective studies at a national
Usually the condition becomes clinically level.
symptomatic in the third stage and the last
With these reservations in mind present
stage is rarely seen.
knowledge suggests that the best treatment
With the present state of our knowledge is surgical synovectomy. This can be per
we cannot determine whether synovial chon- formed even in early childhood— in one of
drometaplasia, which is often limited to a our cases, a bilateral synovectomy performed
certain portion of the synovium, is a tem on a 7-year-old child resulted in excellent
porary condition or whether it is permanent. functional recovery and no sign of recur
Arguments can be put forward for each rence at 2-year follow-up.
view.
To improve treatment, prospective studies
We have found associated systemic con should try to answer the following questions:
ditions with synovial chondrometaplasia, but Does chondroid metaplasia occur in the
only rarely. In our Canadian cases, there whole synovial membrane of a joint or only
were associated vascular conditions in in a particular centre? Can the condition
1.4% , gastrointestinal conditions in 1.4% spread from these particular centres to the
and nervous conditions in 3.6%.
rest of the synovial membrane? Can intraarticular
drug administration or radiation
T reatm ent
therapy alter the metaplastic process of the
Surgery was performed in all Canadian
synovial membrane? Although it is evident
cases since histologic examination was essen
that synovial chondrometaplasia produces
tial for diagnosis of the disease. When
alterations in the synovial circulation, these
chondrometaplasia was recognized at opera
changes have not been investigated; there
tion, synovectomy with removal of all the
fore the role of the synovial blood vessels
visible loose bodies was the treatment of
in different conditions should be clarified.
choice; this was done in 12 of the 18 Cana
dian patients. In the remaining six patients
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COMPUTER-AIDED DIAGNOSIS OF GASTROENTEROLOGIC
DISEASES IN SHERBROOKE: PRELIMINARY REPORT*
JANE C. HORROCKS,f GHISLAIN DEVROEDE, MD
and F. T. de DOMBAL, MD
To assess the diagnostic accuracy of a
computer-aided-diagnosis system when imple
mented in different parts of the world, an auto
mated system, which had established its reliabi
lity in Leeds, England, was transferred to
Sherbrooke, Quebec. In this preliminary study
two retrospective series, comprising 104 pa
tients with acute abdominal pain and 101 patients
with dyspepsia, were drawn from the files of the
Centre Hospitalier Universitaire in Sherbrooke.
The history and physical-examination sheet was
analyzed, coded and tested against the Leeds
data base on a W AN G 2200 computer, and the
results were compared with the final Sherbrooke
pathologic diagnosis. Overall the computer made
a correct diagnosis in 78.8% of cases of acute
abdominal pain and 70% of cases of dyspepsia.
Computer diagnoses of appendicitis were correct
in 97 % of cases and the system recognized 91 %
of the actual appendicitis cases. Similar figures
for cholecystitis were 91 % and for peptic ulcer,
8 7 % . However, the "pick-up” rate by the com
puter of pancreatitis was only 2 5 % . It is con
cluded that geographical differences in disease
presentation will probably not impair the validity
of the computer method used in this study. A
comparison of various diagnostic methods and
levels of competence will await a prospective
trial of this method.
Afin de voir si un systeme de diagnostic
assiste de I'ordinateur garderait sa valeur
dans differentes parties du monde, un systeme
automatique, dont la valeur avait ete etablie a
Leeds, Angleterre, a ete teste au Centre Hospi
talier Universitaire, Sherbrooke, Quebec. Deux
series retrospectives de 104 malades souffrant
d'un abdomen aigu et de 101 malades souffrant
de dyspepsie, ont ete etudiees. L’histoire de cas
a I'admission a ete revue, codee, et un diagnos
tic pose sur un ordinateur W A N G 2200, en lui
donnant comme memoire les cas utilises a

*From the unite de recherche gastrointestinale,
Universite de Sherbrooke, Sherbrooke, Que. and
the department of surgery, Leeds University, Leeds,
England.
tSupported by a grant from the Medical Research
Council of the United Kingdom.
Request reprints to: Dr. G. Devroede, Depart
ment of surgery, Centre Hospitalier Universitaire,
Sherbrooke, PQ J1H 5N4.

Leeds dans ce but. Le diagnostic de I’ordinateur
a ete compare au diagnostic pathologique de
Sherbrooke. Le diagnostic de I'ordinateur etait
correct dans 78.8% des cas d’abdomen aigu et
70% de dyspepsie; 97% des appendicites diagnostiquees par I'ordinateur, etaient de fait des
appendicites, et le systeme a reconnu 91 % des
cas d’appendicites histologiques. Les figures respectives pour la cholecystite et I’ulcere peptique
sont 91% et 8 7 % . Neanmoins I'ordinateur n'a
reconnu que 25% des pancreatites. La difference
geographique que les maladies ici pourraient
avoir en mode de presentation, n’influence done
probablement pas la validite du systeme teste
dans cette etude. Par contre, il faudra attendre
des etudes prospectives pour comparer la va
leur respective des differents moyens de dia
gnostic et determiner les differents niveaux de
competence.

A ttempts have been made in a number

of countries to introduce automated sys
tems designed to facilitate clinical diagno
sis, and indeed predicted diagnoses of such
systems appear to be more accurate than
those of unaided clinicians. Yet a major
question remains in respect of computeraided diagnosis: How applicable are such
systems in different geographical areas?
Would a system from one geographical area
retain its diagnostic accuracy when imple
mented in another?
In an attempt to answer this question,
at least in part, we recently transferred a
system of computer-aided diagnosis from
Leeds, England, to Sherbrooke, Quebec.
We report the methods used, detail some of
the preliminary results, and outline further
problems and perspectives for the future.
Materials

and

M ethods

The methods used in implementing the
computer-aided-diagnosis system in Sher
brooke followed closely those already de
lineated for the Leeds system,1' 2 but a
brief outline and a summary of the differ
ences between the two systems are appro
priate.
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a system by considering two series of un
selected real-life patients.
These two retrospective series comprised
104 patients with acute abdominal pain and
101 patients with dyspepsia admitted the
Centre Hospitalier Universitaire, Sher
brooke between 1970 and 1974. The com
position of each series by disease is shown
in Tables I and II. In both series, because
almost all had an operation, most diagnoses
were based on operative and histopathologic
findings. Occasionally, as in eight patients
with pancreatitis, biochemical evidence was
accepted.

Computer System

We used a small desk-top computer
(WANG 2200; central core store, 8K),
which comprised a central processing unit,
a video display unit and an entering key
board. The programs were originally those
of similar studies in England. These were
written in BASIC language and transferred
on magnetic tape to the Sherbrooke system.
The turn-round time for each case varied
from 1 to 2 minutes and the overall cost of
the system approximated $12 000. The
estimated cost of an individual search was
$0.60.3

M ethods
Patients Studied

of

of

Study

Each case was studied in the following
fashion. The case records were first scrutin
ized, and details of the patient’s clinical
presentation at the time of admission to hos
pital were recorded on a special form (Fig.
1). For the diagnosis in patients with acute
abdominal pain the computer required data
from the history and physical examination,
but for patients with dyspepsia, it needed

Ideally, the efficiency and performance
of any computer system can only be evalu
ated on the basis of a prospective, unse
lected, consecutive, real-time, real-life trial
comparing the computer-aided system with
various modes of “conventional” diagnosis.
As an interim measure, however, we have
tried to estimate the potential value of such
TABLE I.—C omparison

161

THE C A N A D IA N JO U R N A L OF SU RG ER Y

C omputer-aided D iagnosis v . “F inal” C linical D iagnosis
P atients with Acute Abdominal P ain

104

in

Final diagnosis
Computer-aided diagnosis

~AA

ADD

PPU

N ASP

Acute appendicitis (A A )..
Acute diverticular disease

(ADIT:.........................
Perforated peptic ulcer
(P P U )...............................
Nonspecific abdominal
pain (N A SP )..................
Acute cholecystitis (A C )..
Small bowel obstruction
(SBO)...............................
Acute pancreatitis (A P ). .
T otal............................

AC

SBO

nr

rr

-

—

1

2

1

~

34

—
1

1

3

3

8

1

Total

32
3
5

1

-

i

AP

2

8

*Italicized numbers represent correct computer diagnoses.
TABLE II.—Comparison of C omputer-Aided D iagnosis v . “F inal ” Clinical D iagnosis in 101

P atients

with

D yspepsia
Final diagnosis

Computer-aided diagnosis
Functional dyspepsia (FD )
Cholecystitis (C )..................
Peptic ulcer (P U )................
Gastric carcinoma (G C ). .
T otal..............................

FD
1 * .__
—
—

—
1

Italicized numbers represent correct computer diagnoses.

C

PU

GC

Total

8
---- 2 1 ____
9
2

2
2
47
3

3
'— - 2

12
23
59
7

40

54

6

101

1
—

1G2
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CLINICAL DIAGNOSIS : ACUTE ABDOMEN
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HA l t
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SERIAL NUMBER
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0
3.
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4.
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»9.

Protreaa V J o t l t
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Vocnitmf
3.
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fuq utuey
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GENERAL EXAMINATION
Mood M o fc M A l
Colour V30RM M .
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Movement K J o t-H K .
Scan
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Rigidity M o
Swelling! MO
Murphy t l C C M l V f
Bowel Sounds fsMMLH 4 L
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c
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Fig. 1.—Proforma sample showing data from
25-year-old man with acute abdominal pain.
CAD = computer-aided diagnosis.

only details of age, sex and symptoms. This
information was coded and entered into the
computer system. The system generated a
diagnostic probability and a print-out of
the patient’s case history (Fig. 2). The
computer-aided prediction was then com
pared with the clinical diagnosis established
at operation (including the histopathologic
diagnosis where available).
R esults

Acute Abdominal Pain
The distribution of cases between the
disease categories was not equal in this se
ries of 104 patients (Table I); of the “posi
tive” diagnoses the commonest disease cate
gories were appendicitis and cholecystitis.
This reflects a similar distribution found
in previous studies to the United Kingdom.
Overall, 82 (78.8%) cases were correct
ly diagnosed by the computer-aided system,
but there was considerable variation in the
accuracy of the system between the various
disease categories (Table I): the computer
made 32 diagnoses of appendicitis of which
31 (97% ) were correct, and correctly iden-

Mood n o rm a l
C o lo u r - n o r m a l
A bd. m v t. n o rm a l
A b d o m in al s c a r a b s e n t
D is t e n s i o n a b s e n t
T en d ern ess-R L Q
R ebound te n d e r n e s s
G u a rd in g p r e s e n t
R ig id ity ab sen t
S w e llin g a b s e n t
M u rp h y 's s i g n n e g a t i v e
Bow el s o u n d s n o rm a l
R e c t a l e x a m - te n d e r r . s i d e
A ppend
9 9 .9 3

D iv e rt
.0 0

P e rfd u
.0 0

N onsap
.0 6

C h o le
.0 0

Smbobt
.0 0

P a n c re
.0 0

Fig. 2.—Computer print-out from same patient
as for Fig. 1 showing diagnostic prediction of
acute appendicitis. Note than computer ignores
data recorded by clinician as uncertain.

tified 31 (91 %) of the 34 patients with acute
appendicitis; the computer made 32 diag
noses of cholelithiasis, of which 29 (91%)
were correct and correctly identified 29
(91 %) of the 32 patients who had cholecys
titis. This represents an accuracy and reli
ability of over 90% in each case. However,
of the eight patients with pancreatitis the
computer correctly identified only two (a
“pick-up” rate of only 25%).
Dyspepsia
A comparable picture was seen in the
series of 101 patients with dyspepsia (Ta
ble II). Overall the diagnostic accuracy (71
of 101 patients) was modestly encouraging
(70%) and was higher than the diagnostic
accuracy of unaided clinicians reported un
der similar circumstances (50% ).:i However,
the same differences between diagnostic ac
curacy by disease categories is evident. The
computer correctly identified 47 (87%) of
the 54 patients with peptic ulcer but only 2
of the 6 patients with proven gastric carci
noma.
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Fig. 3.—Diagnostic accuracy of computer-aided
system in Leeds' and in Sherbrooke in cases of
acute abdomen, compared with percentage accur
acy of Harvard residents5 and Edinburgh regis
trars (Gunn A, unpublished data, 1975) and
Copenhagen registrars (Bjerregaard B, unpublished
data, 1975).

D iscussion

It has been suggested4 that the potential
value of any computer-aided system de
pends on two factors: (a) its performance
in its place of origin; and (b) transferral to
a different geographical location without a
considerable loss of accuracy and reliability.
It is, therefore, refevant to compare experi
ence in Leeds and in Sherbrooke.
In some respects precise comparisons
concerning performance of this system are
difficult—for example, the cases studied
in Sherbrooke did not form a consecutive,
prospective, unselected series. Thus many
of the categories of data in the case notes
differed from those that would have been
collected in a prospective series; also there
was no attempt to standardize terminology
in this series. And, although the series was
unselected there is no guarantee that the
distribution of cases in this series of 200
patients will accurately reflect the distribu
tion in a prospective series.
Despite these problems, it is worth mak
ing some comparisons between Sherbrooke
and Leeds— particularly because they bias
the results against the computer-aided sys
tem, because there has been no attempt to
standardize the Sherbrooke and Leeds terms
and because case histories written in French
were compared to an English data base.
(Bias in any series is never desirable but
when a “new” method or treatment is be
ing evaluated, any bias should preferably be
“against” the new method). Moreover, one
valid comparison that can be made is that
between the computer’s accuracy in these
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patients and its accuracy in similar retro
spective series of patients studied at the
inception of the Leeds program. For exam
ple, the overall accuracy of the computer in
acute abdominal pain was 79% (Fig. 3),
which compares well with its 84% accura
cy in a retrospective group of 300 cases
studied at the start of the Leeds series.
Moreover, it is apparent from the failure
of the system to identify accurately the
cases of pancreatitis that the diagnostic
term “pancreatitis” has a different mean
ing in Leeds and in Sherbrooke. Therefore,
if we exclude the cases of pancreatitis the
accuracy of computer prediction is very
similar in both centres (84% in Leeds, 83%
in Sherbrooke).

Fig. 4.—Diagnostic accuracy of computer-aided
system in Leeds, and in Sherbrooke in cases of
dyspepsia, compared with accuracy of English3 and
American physicians.3

Results with respect to dyspepsia are also
comparable (Fig. A'- ’■). In initial attempts
in Leeds to construct a data base of infor
mation concerning patients with dyspepsia,
the diagnostic accuracy overall was 70% .
In Sherbrooke the diagnostic accuracy over
all using retrospective case data was 72% .
We have not attempted to make any de
finite comparisons between diagnoses of
clinicians and diagnoses of the computeraided system in this series, because it is
almost impossible in retrospect to assess a
clinician’s diagnosis in the circumstances
facing him at the time. We have attempted
to remedy this drawback by comparing the
accuracy of the computer-aided predictions
with that of various groups of clinicians in
centres where information is available. The
overall accuracy of the computer-aided sys
tem in cases of acute abdominal pain (even
using retrospective case data) is consider
ably higher than that of the average Euro-
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disease category, and, following from this
assumption, that the diagnosis of pancreati
tis should be reviewed and additional ef
forts should be made towards standardiza
tion of this diagnosis around the world.
The overall conclusion from the present
series of studies is that geographical dif
ferences in disease presentation are not per
haps as great as might have been thought,
and there may be in a routine practical
sense, a place for the wider implementation
of the type of computer-aided system de
scribed here. Such an assertion calls for a
prospective randomized, controlled trial and
we hope to undertake further studies of this
nature in the near future as a result of col
laboration between our two centres.

Previous studies have shown that appli
cation of the computer-aided system to
analysis of data from prospective, conse
cutive, unselected series has improved the
diagnostic accuracy over that from retro
spective series. It seems reasonable, on the
basis of the present findings, to postulate
that the same would happen in Sherbrooke,
but all that can be said as a result of the
present series of studies is that transfer of
a small, desk-top, computer-aided system
R eferences
for clinical diagnosis from Leeds to Sher
brooke resulted in little loss of accuracy 1. H orrocks JC, M cC ann AP, Staniland JR,
et al: Computer-aided diagnosis: descrip
and reliability.
tion of adaptable system and operational
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experience with 2,034 cases. Br Med J 2:
5, 1972
poor computer diagnosis of pancreatitis and
the accurate diagnosis of cholecystitis or 2. H orrocks JC: Computer-aided diagnostic sys
tem using small desk-top computer-calcu
appendicitis is extremely interesting. It is
lator. Methods Inf Med 13: 83, 1974
reasonable to conclude that cholecystitis and 3. H orrocks JC, de D ombal FT: Computeraided diagnosis of “dyspepsia”. Am J Dig
appendicitis present in similar fashion in
Dis 20: 397, 1975
Leeds and Sherbrooke, since a computer- 4. de D ombal FT, H orrocks JC, W almsley F,
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aided system working on Leeds data correct
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FAMILIAL POLYPOSIS COLI AND PERIAMPULLARY CARCINOMA*
ALI H. QIZILBASH, MB, BS, FRCP[C]
An
80-year-old
woman
with
periampullary
carcinoma was found, at autopsy, to have
polyposis coli. A brief review of the literature
indicates that, although the association of Gard
ner’s syndrome with duodenal and pancreatic
carcinoma is well established, the patient de
scribed in this report is only the second with
polyposis coli in whom a periampullary carcino
ma developed.
Un cas de polyadenomatose familiale essentielle a ete decouvert a I'autopsie chez une
femme de 80 ans atteinte d'un carcinome
peri-ampullaire. Une breve revue de la litterature revele que bien que ('association du syn
drome de Gardner avec le carcinome du duode
num et du pancreas soit bien reconnue, la
patiente faisant I'objet de cette communication
est seulement le deuxieme cas de polyadeno
matose familiale essentielle chez qui un carci
nome peri-ampullaire est apparu.

T he term polyposis coli is defined as the
condition of multiple adenomatous polyps
lining the mucous membrane of the large in
testine and is used synonymously with
familial polyposis.1 Polyposis coli may oc
cur alone or with other extracolonic abnor
malities. We report a case occurring in
association with periampullary carcinoma:
to the best of our knowledge this is only the
second report of such an association.
C ase R eport

A 77-year-old white woman underwent elec
tive cholecystectomy for a nonfunctioning
cholesterolotic gallbladder in October 1971.
Other intra-abdominal organs appeared nor
mal. She was hospitalized again in August
1972 because of jaundice, abdominal pain,
nausea, vomiting and fever. Percutaneous
transhepatic cholangiography demonstrated
gross dilatation of the common bile duct and
intrahepatic biliary radicles with obstruction
at the lower end of the biliary tract, and lapa
rotomy revealed a hard nodular head of the
pancreas and a dilated, thickened common
bile duct. Carcinoma of the pancreas was diag*From the departments of laboratory medicine,
Henderson General Hospital and McMaster Uni
versity, Hamilton, Ont.
Reprint requests to: Dr. Ali H. Qizilbash, De
partment of laboratory medicine, Henderson Gen
eral Hospital, 711 Concession St., Hamilton, ON
L8V 1C3.

nosed. The common bile duct and pyloroduodenal junction were anastomosed side-toside and a gastrojejunostomy was performed.
Despite intra-abdominal abscess formation,
pulmonary embolization and myocardial in
farction, the patient recovered satisfactorily.
She was hospitalized once more in August
1974 because of a 4-day history of recurrent
chest pain radiating to the right arm and
shoulder, a 4-month history of severe, watery
diarrhea (as many as 20 bowel movements
daily) and weight loss. Abdominal pain with
occasional nausea and vomiting had persisted
since August 1972. Pertinent findings were:
liver, tenderness and enlargement (liver edge,
4.0 cm below the right costal margin); spleen,
palpable; hemoglobin concentration, 11.4 g/dl;
leukocyte count, 10.4 x 107/ (differential,
normal); total serum bilirubin concentration
0.6 mg/dl; serum glutamic oxaloacetic trans
aminase value, 27 IU; alkaline phosphatase
value, 396 IU; stools, positive for occult blood
and Salmonella montevideo but negative for
ova, cysts and parasites; chest radiograph, 1.0cm cavitating lesion in the left upper lobe;
barium enema examination, diffuse diverticulosis and fecal retention; liver scan, patchy
distribution of radioactivity within an en
larged liver and two cold nodules. Results of
electrocardiography and barium meal exam
ination were normal. Metastatic pancreatic
carcinoma was diagnosed. Treatment was
symptomatic and included antibiotic therapy.
However, after two episodes of gastrointestinal
hemorrhage and despite numerous blood
transfusions she died on Oct. 5, 1974.
Autopsy revealed a well-differentiated ade
nocarcinoma (in continuity with the head of
the pancreas) in the region of the ampulla
of Vater. It involved the entire duodenal wall,
the peripancreatic tissue, the inferior vena
cava, and the right retroperitoneal tissues.
Metastases were present in liver, lungs, pleura
and intercostal mucles. The common bile duct
was not involved and the small bowel ap
peared normal. The large bowel from cecum
to rectum was carpeted by hundreds of
polyps (Fig. 1) (diameter, 0.5 to 3.0 cm), ei
ther pedunculated (Fig. 2) or appearing as
small nodules on the mucosal surface; the
largest was a sessile polyp, a villous adenoma,
in the rectosigmoid area (Fig. 3); the others
were adenomatous polyps. Numerous diverti
cula were present in the left colon, and chronic
cholangitis and obstructive pancreatitis were
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demonstrated histologically. Additional find
ings included nonbacterial, thrombotic endo
carditis of mitral valve, small emboli in coro
nary and splenic arteries, and fresh infarcts
of brain, myocardium and spleen.
Family History
Further investigation of the family history
of this patient revealed that other members of
the family, including the patient’s father, and
two of five brothers, had died from car
cinoma of the colon. One of the two brothers
who died has two daughters, both of whom
have had carcinoma of the colon. Also, two
of the patient’s sons have multiple polyposis;
in one carcinoma of the colon has developed.
Complete investigation of the entire family is
now being undertaken.
Fig. 1.—Portion of colon containing numerous
small adenomatous polyps.

Fig. 2.—Section of colon showing minute ade
nomas (hematoxylin and eosin, x 41-

Fig. 3.—Sigmoid colon containing three pe
dunculated, adenomatous polyps (arrows) and a
large, sessile, villous papilloma in centre (half had
been removed for histologic study).

D iscussion

Our patient is of interest for three rea
sons; (a) she presented with symptoms of
periampullary carcinoma 2 years before her
last admission; (b) diarrhea occurred for
the first time at the age of 80 years; and (c)
because of marked fecal retention, the ba
rium enema was not diagnostic, therefore
the diagnosis of polyposis coli was not made
before death. A review of the literature on
polyposis coli is therefore of value.
The association of polyposis coli with os
teomas, epidermoid cysts, soft-tissue tu
mours, abnormal dentition and postoper
ative desmoid tumours was first recognized
by Gardner2’ 3 and is now usually referred
to as Gardner’s syndrome. Polyposis coli
may be associated also with multiple endo
crine adenomas4' 5 and tumours of the brain
(Turcot syndrome).6’ 7
Another interesting association in pa
tients with Gardner’s syndrome is the find
ing of carcinoma of the periampullary re
gion (duodenum, ampulla of Vater and
pancreas).8 At least seven cases have been
reported.8' 13 In the case reported by Capps,
Lewis and Gazzaniga14 carcinoma of the
ampulla of Vater was found in a patient with
polyposis coli but without other stigmata of
Gardner’s syndrome; carcinoma of the colon
and urinary bladder was also present. Our
patient also had no extracolonic signs of
Gardner’s syndrome, but it was difficult to
decide at autopsy, whether the tumour arose
in the head of the pancreas, duodenum or
ampulla of Vater.
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In most patients with polyposis coli, a
family history is obtained and evidence of
the disease can be traced through many
generations. The condition is transmitted as
an autosomal dominant.15 Occasionally,
however, cases of nonfamilial polyposis coli
are encountered. In Bussey’s view15 non
familial cases are nearly always attributable
to new mutation, and transmission of the
disease is just as likely as in familial cases.
Familial polyposis is generally regarded
as a disease of youth, but patients may be
middle-aged or even elderly before symp
toms appear.15 The polyps usually do not
appear before 10 years of age though re
ports of cases as early as 13 months of age
have been published.16 At St. Mark’s Hos
pital, London, the oldest patient with mul
tiple polyposis at the time of diagnosis was
73 years.17 Our patient who was 80 years
old at the time of diagnosis appears to be
the oldest patient reported with this condi
tion. The mean age of patients with polypo
sis coli in whom carcinoma subsequently de
velops is 40 years.17 In the series reported
by Asman and Pierce,18 in which the mean
age was 38.8 years, carcinoma was present
at the time of diagnosis of polyposis coli
or 2 years thereafter in 49% of their symp
tomatic patients. However, cancer was de
tected in only 12% of the asymptomatic
patients, indicating the importance of symp
toms in planning surgical treatment. In
our patient symptoms were only of 4
months’ duration and no carcinoma of the
colon was found at autopsy; all of the po
lyps found in the large bowel were benign,
adenomatous polyps except for the largest
one situated in the rectosigmoid region,
which was a villous papilloma. Most re
ports refer to the polyps found in familial
polyposis as adenomas, though rare villous
tumours have been described.17
Familial polyposis was thought to repre
sent a disease primarily of the large intes
tine, but recently it has become apparent
that many patients with this condition have
extracolonic signs, supporting the concept
put forward by Smith19 that there is one
gene for both Gardner’s syndrome and fa
milial polyposis, with a variation in pen
etrance accounting for the different clinical
pictures. Our case would support such a
concept.

Vol. 19

I thank Dr. W. R. McMillan for permission to
review the case and to interview members of
the family.
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CONGENITAL HIP DISLOCATIONS DIAGNOSED AFTER WALKING
AGE: RESULTS OF TREATMENT*
MICHAEL A. ROSMAN, MD, FRCS[C]
The results of treatment of 64 congenital
hip dislocations, diagnosed after the children
were of walking age, were assessed ana
tomically, using two criteria— general fem
oral head shape and the C.E. angle of Wiberg.
Results were also related to age at diagnosis
and treatment methods. Radiologically 62% of
the hips had normal or good results, and of
these, 82% were obtained when the diagnosis
was made and treatment started before the age
of 36 months. In this series no correlation ex
isted between anatomical result and treatment
method.
Les resultats therapeutiques obtenus dans
64 cas de dislocation congenitaie de la
hanche diagnostiques apres que les enfants
eurent atteints I’age de marcher, ont ete evalues
selon deux criteres: la forme generale de la
tete femorale et Tangle C.E. de Wiberg. Les re
sultats ont aussi ete evalues en fonction de
I'age au moment du diagnostic et de la methode
de traitement. A la radiographie, 62% des han
d le s etaient normales ou montraient de bons
resultats; 82% de ces resultats furent obtenus
lorsque le diagnostic fut pose et que le traite
ment commenca avant i'age de 36 mois. Dans
cette serie il n'y avait aucune correlation entre
le resultat anatomique et la methode de traite
ment.

T he results of treatment for congenital dis

location of the hip depend on the age at
which the diagnosis is made and the treat
ment initiated.1' 4 Generally, the earlier the
diagnosis is made the better the result, both
clinically and radiologically. In the few pa
tients in whom the dislocation is not diag
nosed until the child begins to walk, results
are usually less satisfactory.
The purpose of this study was to assess
the results of treatment in these older chil
dren and to correlate the results with the
age of the child at the time of the diagnosis
and the method of treatment.
*From the department of orthopedic surgery,
Montreal Children’s Hospital, Montreal, Que.
Presented at the meeting of the Canadian Ortho
paedic Association, St. John’s, Nfld, June 1974.
Reprint requests to: Dr. M. A. Rosman, Depart
ment of orthopedic surgery, Montreal Children’s
Hospital, 2300 Tupper St., Montreal, PQ H3H 1P3.

D etails of P atients,
and T reatment

M ethods

Unilateral or bilateral congenital hip dis
location was diagnosed after walking age in
53 children (46 girls) during the 15 years
1959 through 1973; 64 hips were examined
(42 unilateral, 11 bilateral). Each hip was
assessed individually. Initially all patients
were treated by traction and open adductor
tenotomy, and, after reduction, with spicacast immobilization.
The age range at the time of diagnosis
was 11 months to 13 years (average, 3.5
years). Patients with unilateral dislocation
were seen earlier than those with bilateral
dislocation. Follow-up ranged from 5 to
12.6 years (average, 7.7 years).
Methods used to reduce the hip disloca
tion were as follows: open reduction, 37
hips; closed reduction, 26; closed then open
reduction, 12; open followed by repeat open
reduction, 4. Fifty-five associated pro
cedures were done at the time of reduction
or later (derotational osteotomy, 32 hips;
innominate osteotomy, 17; varus osteotomy,
3; other, 3).
M ethod

of

A ssessment

The 64 hips were reassessed clinically and
radiologically. Subjective complaints were
minimal and objective findings, such as
limited range of motion, pain on motion,
awkward gait, shortening and weakness,
were not grossly abnormal and did not in
terfere with function.
In the radiologic reassessment of the hips
we used two criteria: the C.E. angle of
Wiberg*5 and the general shape of the
femoral head and acetabulum classified by
Somerville (normal [radiologically normal],
good [showing signs of subluxation], fair
[dysplasia], or poor [deformity]).4
A normal hip has a C.E. angle of over
35° and appears normal radiologically; a
*A line joining the centre of the femoral head and
the edge of the acetabulum subtends an angle with
the centre of the femoral head. A normal hip
has an angle of 20 to 40°; an angle less than 20°
represents subluxation and an angle greater than
40° represents protrusion.
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Fig. la

Fig. lb
Fig. 1.—(a) Congenita! hip dislocation in 2 Vi-year-old girl. Treatment was by closed reduction
only, (b) Normal result, 9 years later, correlating anatomically normal-shaped femoral head to C E.
angle o f 35 .
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Fig. 2a

Fig. 2b
Fig. 2.—(a) Initial dislocation in 15-month-old girl. Dislocation was treated by closed reduction
and derotational osteotomy. Acetabular roof did not develop with abduction splinting; redislocation
occurred 2 years later and was treated by open reduction, (b) Nine years after initial dislocation,
anatomical assessment was poor and C.E. angle was 4°.
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good hip has a C.E. angle of 20 to 34°
either with Shenton’s line intact and slight
uncovering of the femoral head or with
Shenton’s line slightly broken and the head
bulging; fair and poor hips have C.E. angles
of less than 20° with misshapen and incon
gruous femoral heads, deformed acetabula
and broken Shenton’s lines.
R esults
By the anatomic grading of Somerville
and the C.E. angle of Wiberg, 40 hips were
reassessed as normal or good (C.E. angle,
> 35° to 20°) while 24 hips were fair or
poor (C.E. angle 19° to < 10°). The ana
tomic grading and the C.E. angle closely
parallelled each other (Figs. 1 and 2).
TABLE
Age at
diagnosis
(mo)
11 - 2 4
25 - 36
37 - 48
> 48
Total

I.— A g e

at D iagnosis
A natomic R esults

R elated

to

Results
Normal

Good

Fair

Poor

5
14
4
2
25

9
5
0
1
15

0
0
12
2
14

1
0
1
8
10

Table I illustrates the relationship be
tween the age at diagnosis and anatomic
result: 40 (62.5%) of the 64 hips were
reassessed as normal or good, and of these
40, 33 (82.5% ) resulted when the diag
nosis was made before 36 months of age.
When the diagnosis is made later, the re
sult is often poor—in 23 (96%) of the 24
hips reassessed as fair or poor the disloca
tion was diagnosed after 36 months of age.
When the overall number of patients and
their age at diagnosis (at 6-month intervals)
were examined in relation to the radiologic
results of all hips we found that there was
a greater proportion of more favourable
radiologic results in patients when the diag
nosis was made and treatment begun at an
age under 36 months.
A comparison of two groups of anatomic
results (normal, good and fair, poor) re
lated to treatment (Table II), indicates that
each group had slightly more than one re
duction per hip, and additional or associated
procedures averaged close to one per hip. It
appears, therefore, that the type of reduc
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tion and the associated procedures did not
affect the anatomic grade in this series.
Complications were recorded for 35 of
the hips. There were four instances of
avascular necrosis associated with closed
reduction.
D iscussion
In the treatment of congenital hip dis
location, the need for preliminary traction,
usually skeletal, in children of walking age
has been stressed.6’ 7 In our series it was
combined with open adductor tenotomy.
Management of hip dislocation is easier and
results are better, if the diagnosis is made
before walking age; in those children whose
dislocated hips are not diagnosed until after
they have begun to walk, a greater number
of reductions, open and closed, and addi
tional procedures, may be required. Con
centric reduction is necessary to ensure not
only stability but also good long-term ana
tomic results, whether these are achieved by
open or closed methods.2- 3- 7
Because the response of the acetabular
roof in children over 18 months of age is
not uniform or predictable, even after a
concentric reduction, pelvic osteotomy of
some type may be required.7 However, in
the opinion of Somerville4 the acetabular
roof will respond after 18 months, if the
femoral head is kept centered, either by
prolonged abduction splinting or varus
osteotomy. If reduction is combined with
acetabular redirection, the forced internal
rotation that is required to maintain reduc
tion, and is due to increased anteversion,
will be unnecessary. Perfect results are
never expected in any child in whom the
diagnosis is made and treatment started
after walking age because operative recon
struction can never match natural reforma
tion of the hip joint, but in our series no
TABLE II.—T reatment R elated

to

Anatomic

R esults

Results

Form of reduction:
Closed
Open
Other procedures

Normal
and good
(n = 40)

Fair
and poor
(n = 24)

24
24
30

11
20
25
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patient or parent was dissatisfied with the
result.
Our findings suggest that, subjectively and
functionally, these children do well, but
that, objectively, the results are less accept
able. The current treatment of hip disloca
tions diagnosed after walking age consists
of gentle preliminary traction following
open adductor tenotomy, then open reduc
tion of the hip joint. Innominate osteotomy,
done at the same time as the open reduction
or several weeks later, ensures stability and
coverage by the overlying acetabular roof
and minimizes immobilization and stiffness.
The age of the child at the time of diag
nosis was the only factor that appeared to
influence the overall results in our series:
if diagnosis was made and treatment begun
after walking age, there was a 66% chance
of an acceptable result, and if the patient
was under 36 months of age, there was an
80% chance of an acceptable result. The
findings of this study suggest that a more
uniform approach to the treatment might
have produced a greater number of normal
and good results.
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COMMON DUCT STONES. Frank Glenn.
135 pp. Illust. Charles C Thomas, Pub
lisher, Springfield, IL, 1975. $11.50.

The management of common duct stones re
mains one of the general surgeon’s most dif
ficult problems. Most surgeons who treat
biliary tract disease are familiar with the many
contributions to the literature on this subject
by Dr. Glenn. This small monograph presents
an interesting history of the development of
biliary tract surgery from the earliest obser
vations in the 5th century to the present. Case
reports are used to illustrate the advance in
knowledge and increasing success of treat
ment; the history of the development of
radiology as it pertains to biliary tract disease
is also described. The development of common
duct surgery and the various clinical syn
dromes produced by stones in the common
duct are discussed and then the technique and
results of common duct drainage and decom
pression are considered. The various methods
of dealing with retained common duct stones,
including the use of various solvents, instru
mentation and surgical exploration are re
viewed.
This is not a book on surgical technique
but an interesting story of the development
of biliary tract surgery. It contains many ob
servations (based on a wide experience) that
are not usually found in a textbook or journal.
Most general surgeons will find it interesting.

patients of this age group, and it is on this
basis that the author, in the ensuing chapters,
discusses the clinical evaluation of the newborn
infant and the signs and symptoms of changes
in homeostasis and presents rational schemes
for correction of these changes.
Fluid therapy and blood replacement during
surgery are considered in general terms, and
specific pathologic entities in more detail. A
separate chapter is devoted to the evaluation
and preparation of the infant with pyloric
stenosis before operation. Short chapters are
also included on intravenous alimentation and
fluid balance in infants receiving respiratory
therapy. Specific examples of the correction of
various electrolyte and fluid derangements are
included where appropriate. The references in
each chapter are complete and plentiful.
This relatively short book is an excellent
practical guide to current concepts of fluid
therapy in the pediatric surgical patient.
E. J. R h in e
Department of anesthesia,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
MAJOR AMPUTATIONS FOR VASCULAR
SURGERY. Edited by J. M. Little. 114 pp.
Illust. Churchill Livingstone, Edinburgh;
Longman Canada Limited, Toronto, 1975.
$18.00.

D. E. M o r r is
Department of surgery,
Victoria General Hospital,
Halifax, NS.
FLUIDS FOR ANESTHESIA AND SUR
GERY IN THE NEWBORN AND THE
INFANT. E. J. Bennett and J. P. Payne.
232 pp. Charles C Thomas, Publisher,
Springfield, IL, 1975. $18.50.

For the occasional pediatric surgeon or anes
thetist the management of electrolyte and fluid
balance of the newborn or infant is often beset
by problems. This book succinctly (and at
times dogmatically) sets forth guidelines to
prevent the occurrence of many of the hazards,
should they occur, and to indicate treatment.
In the initial chapters renal physiology and
homeostasis are discussed as they apply to

In this book, which should interest all medical
and paramedical personnel responsible for the
care of amputees, Little stresses the natural
history and management of the patient and
relates his personal experience with the am
putee clinic at the Royal Prince Alfred Hospital
in Sydney, Australia and he stresses the im
portance of a rehabilitation program in the
management of these patients.
Little’s book, in general, is useful but cer
tain omissions are evident and several other
points merit comment. For example, I won
dered why the author does not use delayed
secondary wound closure of the amputation
stump, for he discusses the problems of hema
toma, ischemia, and infection in the stump,
and reports a wound complication rate in his
own cases of 30%. I also noted that the
author failed to report on the two-stage Syme
amputation, advocated by Wagner.
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In our experience, because of severe pain
in our patients before amputation, we have
had little success with preoperative gait train
ing, and would not approve of the use of ice
on the skin of ischemic limbs. We still believe
that the ability to use crutches efficiently is
the best indicator of the patient’s capabilities
for prosthetic training. Despite these points,
this book was a pleasure to review.
G. A. H u n t e r
Department of surgery,
St. Michael’s Hospital,
Toronto, Ont.
RECENT TRENDS IN CARDIOVASCULAR
AND THORACIC SURGERY. Edited by
Joseph B. Borman. 222 pp. Illust. Grune &
Stratton, Inc., New York; Longman Canada
Limited, Toronto, 1975. $20.25.

What can one really say about a compilation
of articles by authorities in their respective
fields in a volume dedicated to Hanoch Milwidsky who, until his untimely death in Feb
ruary 1970, was director of the division of
cardiovascular and thoracic surgery at the
Hadassah University Hospital in Jerusalem?
To be critical would border on being disre
spectful! However, virtually all the information
contained in this book has already been pub
lished, and republished, in the available surgical
literature. Yet another operation for esophageal
stricture is described and several articles em
phasize that war is bad. On the other hand,
Lord Brock’s article is like a breath of fresh
air and should be read by all modern-day
heart surgeons, who seem incapable of doing
even a pericardiectomy without “pump sup
port”.
I can find little reason to recommend this
book except to those who do not have access
to a medical library.
R. B. L y n n
Cardiovascular and thoracic surgery,
Queen’s University,
Kingston, Ont.
SALIVARY GLANDS AND THE FACIAL
NERVE. John Conley. 391 pp. Illust. Grune
& Stratton, Inc., New York, George Thieme
Publishers, Stuttgart; Longman Canada
Limited, Toronto, 1975. $98.00.

text, dealing primarily with diagnosis and
treatment and based on personal experience,
he draws on a clinical background of 1210
cases of salivary gland tumours from the Pack
Medical Foundation and 1280 tumours from
the Columbia Presbyterian Medical Center.
The format is pleasing and well or
ganized, with large, easy-to-read print. It is
profusely illustrated. The book is divided into
two sections: The first deals with the anatomy
of the salivary glands and the pathology, diag
nosis and treatment of benign and malignant
tumours; the second refers entirely to the
facial nerve and its relation to salivary gland
tumours, its surgical anatomy and the tech
niques used to restore its function (including
facial nerve grafting, nerve cross-over, re
gional flap transpositions, etc.).
Dr. Asher Kleinsasser’s description of epi
thelial tumours of the parotid gland, based on
studies conducted at the ear, nose and throat
clinic at Cologne University, is excellent. In
these studies, all salivary gland tumours were
studied microscopically, electronmicroscopically and histochemically. Electronmicroscopic
illustrations of several tumours are beautifully
shown.
A well-written chapter on non-neoplastic
diseases of the parotid glands by Walter P.
Work covers inflammation, metabolic and en
docrine disorders, embryonic disturbances,
cysts and trauma and contains an extensive
bibliography.
The pathology of salivary gland neoplasms,
outlined by Drs. Marianne Wolff and Raffaele
Lattes, is disappointingly brief and without
adequate description of the gross microscopic
features of benign and malignant lesions.
Three excellent chapters are those on parotid
gland tumours in children, the gustatory
sweating syndrome and the role of radiation
therapy in the management of malignant
tumours of the salivary gland.
In the final portion of the book, variations
in facial nerve anatomy together with tech
niques of facial nerve reconstruction are well
described and illustrated.
This text is highly recommended for those
with a particular interest in head and neck
neoplasms—the otolaryngologist, general sur
geon, plastic surgeon, maxillofacial surgeon
and radiotherapist.
E. J. T abah

The author is congratulated for putting to
gether an excellent, masterful monograph on
the salivary glands and facial nerve. In this
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